etoposide has been researched along with Liver Neoplasms in 303 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (6.60) | 18.7374 |
| 1990's | 86 (28.38) | 18.2507 |
| 2000's | 105 (34.65) | 29.6817 |
| 2010's | 70 (23.10) | 24.3611 |
| 2020's | 22 (7.26) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, J; Gao, Y; Guo, Q; Tang, Y; Zhang, S; Zhu, X | 1 |
| Chen, JT; Ma, R; Mu, Q; Sun, SC; Xu, XL; Zhu, XF | 1 |
| Deng, X; Lei, F; Li, Z; Liu, D; Luo, T; Shi, T; Wang, Z; Wen, H; Yang, X; Zhang, H; Zhao, Q | 1 |
| Deng, X; Jiang, W; Li, Y; Liu, L; Luo, T; Wang, Z; Xie, L; Zhang, X | 1 |
| Akiyama, M; Goto, H; Hasegawa, D; Honda, T; Kumamoto, T; Ogawa, S; Takagi, M; Terao, YM; Yamaoka, M; Yoshida, K | 1 |
| Ballenberger, M; Harshan, M; Indaram, M; Machnicki, S; Mina, B; Novoselac, AV; Singh, A; Vojnic, M | 1 |
| Chang, CH; Chang, YL; Chen, JS; Hsu, FM; Huang, YL; Lee, JM; Lin, CC; Ma, WL; Yang, JC | 1 |
| An, J; Cao, L; Chen, C; Deng, P; Gu, Q; He, B; Hu, C; Jiang, J; Li, M; Qin, L; Yang, H | 1 |
| Labbozzetta, M; Notarbartolo, M; Occhipinti, C; Poma, P; Sajeva, M | 1 |
| Akino, Y; Fujiwara, K; Higashinaka, N; Isohashi, F; Kouno, T; Mabuchi, N; Ogawa, K; Seo, Y; Shiomi, H; Tamenaga, S | 1 |
| Angulo-Zamudio, UA; Arredondo-Beltrán, IG; Bolscher, JGM; Canizalez-Roman, A; León-Sicairos, N; Nazmi, K; Ramírez-Sánchez, DA; Velazquez-Roman, JA; Zazueta-García, JR | 1 |
| Kim, KD; Lee, KY; Shin, WY | 1 |
| Chen, M; Han, H; Lin, X; Lv, T; Qiu, G; Song, Y; Xie, J; Xu, K; Ye, J; Zhan, P | 1 |
| Cao, J; Cao, M; Du, L; Feng, J; Jin, J; Li, X; Liang, S; Shen, B; Wang, H; Wang, J; Yu, J; Zhang, J; Zhang, Y; Zhou, Y; Zhu, T | 1 |
| Gao, Y; Gu, H; Hu, H; Huang, D; Li, F; Li, J; Liao, R; Wu, R; Zhang, W; Zhang, Y; Zhi, T | 1 |
| Häberle, B; Maxwell, R; Schmid, I; Schweinitz, DV | 1 |
| Aye, J; Beierle, EA; Clay, MR; Coleman, A; Hoppmann, A; Mroczek-Musulman, E; Ranganathan, S; Tynes, C; Whelan, KF; Williams, AP; Williams, GR | 1 |
| Han, Y; Li, L; Sun, H | 1 |
| Czauderna, C; Galle, PR; Heil, E; Heinrich, B; Heinrich, S; Kloeckner, R; Koch, S; Marquardt, JU; Philippe P Diggs, L; Schmidtmann, I; Sprinzl, M; Weinmann, A; Wörns, MA | 1 |
| Gloude, N; Lauhan, CR; Schiff, D | 1 |
| Angelini, P; Cecil, T; Chisholm, JC; Dayal, S; Okoye, B; Sjoberg Bexelius, T | 1 |
| Chen, P; Liu, H; Liu, Y; Qian, C; Qu, Y; Tang, L; Xin, Y; Xu, Y | 1 |
| Chen, TC; Dai, SH; Tsai, WH; Zeng, YH | 1 |
| Fujita, M; Hashimoto, D; Inaba, Y; Ninomiya, R | 1 |
| Akashi, K; Ariyama, H; Baba, E; Doi, G; Harimoto, N; Itoh, S; Kohashi, K; Kusaba, H; Maehara, Y; Nio, K; Oda, Y; Odawara, J; Shimoda, S; Takayoshi, K; Tsuchihashi, K; Tsuruta, N; Yoshihiro, T | 1 |
| Chen, CC; Chen, CY; Chou, LF; Ho, JY; Hsueh, C; Ueng, SH; Wang, TH; Yeh, CT | 1 |
| Cen, P; Dinh, B; Mays, SR; Patel, AB; Rios, A | 1 |
| Nazha, B; Owonikoko, TK | 1 |
| Hamano, Y; Hyodo, I; Moriwaki, T; Sakashita, S; To, K; Watahiki, T; Yamada, T | 1 |
| Laczkó, D; Marchand, B; Pitarresi, JR; Reichert, M; Rustgi, AK; Suzuki, K | 1 |
| Gawdi, A; Mubarak, M; Singal, AK | 1 |
| Auerbach, C; Cheron, R; Natarajan, E; Pashankar, F | 1 |
| Awad, W; Mashni, O; Qasem, K; Sara, AA | 1 |
| Angarita, FA; Meek, E; Rodríguez, JL; Sánchez, JO; Tawil, M; Torregrosa, L | 1 |
| Li, QG; Tong, Y; Xia, Q; Xing, TY; Zhang, JJ; Zhang, M | 1 |
| Al-Jiffry, BO; Al-Malki, O | 1 |
| Calabrese, D; Dietsche, T; Dill, MT; Duong, FH; Heim, MH; Ketterer, S; Makowska, Z; Matter, MS; Terracciano, L | 1 |
| Frikha, M; Khanfir, A; Kridis, WB; Triki, F | 1 |
| Amiri, F; Jeddi-Tehrani, M; Koohdani, F; Vafa, M; Zand, H; Zarnani, AH | 1 |
| Cui, Z; Jiao, T; Li, Z; Liu, N; Peng, J; Ye, X; Zhang, J | 1 |
| Kotwall, CA; Powell, JL; Shiro, BC | 1 |
| Bailly, C; Bal-Mahieu, C; Boulet, E; Guilbaud, N; Kruczynski, A; Lansiaux, A; Lartigau, E; Leblond, P; Meignan, S; Pillon, A; Sarrazin, T | 1 |
| Bekci, T; Danacı, M; Mehmet Selim, N; Özdemir, M | 1 |
| Lonial, K; Noyes, AM; Siegel, RD | 1 |
| Cheong, J; Jung, HU; Kim, HY; Park, BS; Yoo, KS; Yoo, SH; Yoo, YH; Yun, I | 1 |
| Ahmad, S; Ahmed, M; Al-Badawi, IA; Al-Hashem, H; Al-Hayli, S; Al-Husaini, H; Darwish, A; Edesa, W; Elghamry, W; Elhassan, T; Eltigani, A; Madkhali, I; Omar, A; Soudy, H | 1 |
| Cao, J; Ding, L; Liang, G; Luo, P; Ma, S; Shi, S; Wang, D; Weng, Q; Yao, Z; Yuan, C; Zhu, H; Zhuang, K | 1 |
| An, L; Chen, Y; Feng, F; Gao, X; Lu, Y; Qu, J; Sun, H; Wang, C; Wang, F; Yang, Y; Zeng, Z; Zhang, C | 1 |
| Benhamouche, S; Di Martino, J; Javary, J; Neaud, V; Raymond, AA; Rosenbaum, J | 1 |
| Min, J; Wang, Q; Xu, Z; Yang, M; Zhang, AQ | 1 |
| Kapuria, D; Qasem, A; Strasser, K | 1 |
| Bolze, PA; Golfier, F; Hajri, T; Lotz, JP; Massardier, J; Riedl, C; Schott, AM; You, B | 1 |
| Akimoto, Y; Harada, R; Hata, H; Horiguchi, S; Kato, H; Matsumoto, K; Noma, Y; Okada, H; Sakae, H; Tomoda, T; Tsutsumi, K; Uchida, D; Yagi, T; Yamamoto, K; Yamamoto, N; Yanai, H | 1 |
| Cao, Y; Feng, F; Hou, MX; Jia, H; Jiang, QY; Ma, HD; Sun, HW; Wang, T; Yang, Q; Yang, YP | 1 |
| AbAziz, A; Kamaruddin, NA; Mustafa, N; Sukor, N; Wahab, NA; Zainudin, S | 1 |
| Hishiki, T; Hiyama, E; Hoshino, K; Ida, K; Iehara, T; Koh, K; Kurihara, S; Onitake, Y; Oue, T; Tanaka, Y; Ueda, Y; Watanabe, K; Yano, M | 1 |
| Jeong, HY; Kang, SH; Kim, DK; Kim, MH; Moon, HS; Seong, JK | 1 |
| Pagliaro, LC | 1 |
| Hosoda, Y; Imamura, M; Kawai, J; Kiyochi, H; Komoto, I; Nishiyama, K; Ogura, N; Okabe, A; Oshima, Y; Sugimoto, T; Taki, Y; Tsunekawa, S | 1 |
| Akiyoshi, T; Matsuyama, K; Matzno, S; Nakabayashi, T; Yamaguchi, Y | 1 |
| Filatova, LV | 1 |
| Bode, HH; Bode, U; Schimana, W; Swai, B | 1 |
| Behnamfar, F; Mousavi, SA | 1 |
| Hashimoto, M; Ishiyama, K; Nanjo, H; Sato, T; Sugawara, M; Yamamoto, Y | 1 |
| Kinukawa, N; Kunoki, N; Moriyama, M; Nishiyama, R; Ogawa, M; Ogihara, A; Oonishi, M; Ryuzaki, H; Sou, K; Tanaka, N; Uno, A; Yamamoto, T | 1 |
| Bao, Y; Chen, M; Chen, YY; Gao, JM; He, H; Hu, X; Liu, Y; Poudel, S; Sun, ZW; Wang, WH; Wang, Y; Zhang, L; Zhuang, TT | 1 |
| Gutweiler, JR; Kim, HB; Kozakewich, HP; Marcus, KJ; Shamberger, RC; Weldon, CB; Yu, DC | 1 |
| Chen, D; Li, M; Rayburn, ER; Wang, H; Zhang, J; Zhang, R | 1 |
| Fang, JH; Jiang, W; Liang, C; Qiu, FE; Shen, Y; Xiong, XD; Zhuang, SM | 1 |
| Sun, YK; Wang, JW; Zhan, XK; Zhang, W | 1 |
| Al Balushi, Z; Bulduc, S; Lallier, M; Mulleur, C | 1 |
| Britschgi, A; Britschgi, C; Fey, MF; Helin, K; Jenal, M; Leprince, D; Roh, V; Tobler, A; Trinh, E; Tschan, MP; Vorburger, SA | 1 |
| Chen, J; Dong, L; Gu, LJ; Jiang, H; Pan, C; Tang, JY; Xue, HL; Ye, QD; Zhou, M | 1 |
| Chiang, PC; Guh, JH; Hsu, JL | 1 |
| Fujii, M; Funada, T; Kaiga, T; Kanamori, N; Kochi, M; Takahashi, T; Takayama, T | 1 |
| Chen, GG; Lai, PB; Song, G; Yun, JP | 1 |
| Hagihara, A; Hiraoka, N; Ikeda, M; Iwasa, S; Kojima, Y; Kondo, S; Mitsunaga, S; Morizane, C; Nakachi, K; Okusaka, T; Tanaka, T; Ueno, H | 1 |
| Bazin, IS; Fedyanin, MY; Garin, AM; Kanagavel, D; Narimanov, MN; Pokataev, IA; Tjulandin, SA; Tryakin, AA; Yakovleva, ES | 1 |
| Horiuchi, K; Kondo, Y; Mizutani, S; Ohgaki, K; Sato, M | 1 |
| Ikegame, K; Imai, Y; Inoue, D; Kimura, T; Kurata, M; Matsushita, A; Mori, M; Nagai, K; Nagai, Y; Ogawa, H; Shimoji, S; Tabata, S; Takahashi, T; Togami, K | 1 |
| Cho, SJ; Choi, JS; Kim, HY; Lee, SK; Lee, WH; Park, BD; Park, JH; Surh, YJ | 1 |
| Feng, FY; Liu, P; Qin, Y; Shi, YK; Xing, PY | 1 |
| Fujisawa, M; Miyake, H; Muramaki, M; Takenaka, A; Terakawa, T | 1 |
| Hishiki, T; Hiyama, E; Horie, H; Ida, K; Kamimatsuse, A; Kondo, S; Matsunaga, T; Ohnuma, N; Oue, T; Sasaki, F; Tajiri, T; Watanabe, K; Yano, M | 1 |
| Couvelard, A; Dokmak, S; Hammel, P; Hentic, O; Lévy, P; Maire, F; O'Toole, D; Rebours, V; Ruszniewski, P; Sauvanet, A; Zappa, M | 1 |
| Araki, M; Hasegawa, H; Ikura, Y; Itoh, M; Kuzushita, N; Mita, E; Nakazuru, S; Ohta, M; Suemura, S; Toyama, T; Yoshio, T; Yoshioka, C | 1 |
| Amano, J; Eguchi, T; Hamanaka, K; Hyogotani, A; Kobayashi, N; Koizumi, T; Kondo, R; Kurai, M; Saito, G; Shiina, T; Yoshida, K | 1 |
| Feng, F; Geng, S; Wan, X; Wang, T; Xiang, Y | 1 |
| Ai, ZL; Gao, C; Jin, B; Lv, DC; Ma, DL; Shu, XM; Wu, CL; Xie, BS; Yao, SK; Zhao, HC; Zhuo, DX | 1 |
| Chen, T; Fan, J; Gao, Q; Gu, J; He, X; Hu, X; Hui, X; Li, J; Wan, D; Wang, T; Wang, X; Yan, M; Yao, M; Zhao, Y | 1 |
| Chen, GG; Lai, PB; Zhang, CZ; Zhang, HT | 1 |
| Aksu, C; Başaran, M; Bavbek, S; Ekenel, M; Keskin, S; Kiliçaslan, I; Tunç, M | 1 |
| Abdulghani, J; Allen, JE; Dicker, DT; Dolloff, NG; El-Deiry, WS; Gallant, JN; Hong, B; Katz, SI; Navaraj, A; Smith, CD; Wang, W | 1 |
| Akiyama, S; Gamoh, M; Narasaka, T; Niitani, T; Ohto, T | 1 |
| Cyriac, S; Rajendranath, R; Sagar, TG; Sridevi, V | 1 |
| Bollag, WB; Liu, F; Liu, K; Liu, Q; Robertson, K; Wu, P; Yang, D | 1 |
| Asha, HS; Chacko, RT; Eapen, A; Fleming, JJ; Hepzibah, J; Kapoor, N; Ramakrishna, B; Somasundaram, N; Thomas, N | 1 |
| Cho, YJ; Duk Lee, J; Go, SI; Hwang, YS; Jeong, YY; Kim, DC; Kim, HC; Ko, GH; Lee, GW; Lee, JH; Lee, JS; Oh, S; Yang, JW | 1 |
| Patel, S; Rao, P; Richey, SL; Tannir, NM; Wood, CG | 1 |
| Huang, JJ; Jiang, WQ; Li, ZM; Xia, Y; Zhu, YJ | 1 |
| Alaggio, R; Bisogno, G; Cecchetto, G; Cheng, L; d'Amore, ES; Dall'Igna, P; Martignoni, G; Sperlì, D | 1 |
| Becheanu, G; Cerban, R; Gheorghe, C; Gheorghe, L; Serban, V | 1 |
| Choi, YH; Kwon, TK; Lee, JS; Oh, JS; Park, BS; Park, C; Song, YS; Yoo, SH; Yoo, YH; Yoon, YG | 1 |
| Ash, S; Cohen, IJ; Feinmesser, M; Kornreich, L; Kuperman, AA; Yaniv, I | 1 |
| Couvelard, A; Gillet, A; Goujon, G; Hammel, P; Hentic, O; Lévy, P; Maire, F; Palazzo, M; Rebours, V; Ruszniewski, P; Zappa, M | 1 |
| Arnould, T; De Backer, O; Flamant, L; Hayez, A; Michiels, C; Pierre, M; Poumay, Y; Roegiers, E; Sterpin, C | 1 |
| Fujii, Y; Kihara, K; Komai, Y; Noguchi, N; Waseda, Y; Yano, A | 1 |
| Chen, W; He, Y; Peng, J; Song, W; Zhang, S | 1 |
| Jaiswal, AK; Niture, SK | 1 |
| Daliani, DD; Logothetis, CJ; Papandreou, CN; Reyes, A; Thall, PF; Troncoso, P; Tu, SM; Wang, X | 1 |
| Beloqui, O; Bilbao, I; Herrero, JI; Prieto, J; Quiroga, J; Rios, R; Sangro, B | 1 |
| Bowman, LC; Douglass, EC; Finegold, MJ; Katzenstein, HM; London, WB; Plaschkes, J; Reynolds, M | 1 |
| Ahn, SG; Jeong, SW; Kim, BE; Kim, HS; Kim, IK; Kim, JW; Lee, JH; Rhim, H; Shim, JY | 1 |
| Cao, WJ; Huang, W; Li, DJ; Liu, WL; Zhang, YZ | 1 |
| Cai, MM; Chen, C; Chen, S; Gu, JX; Hu, Y; Yan, J; Zhang, S; Zhang, SW; Zhu, XY | 1 |
| Krüger, I; Lindenfelser, R; Scherwitz, P | 1 |
| Bolton, M; Copur, S; Frankforter, S; Fruehling, RM; Ledakis, P; Mleczko, KL; Muhvic, J; Norvell, M; Novinski, D; VanWie, E | 1 |
| Berardi, R; Cappelletti, C; Cellerino, R; Latini, L; Lippe, P; Massacesi, C; Mattioli, R | 1 |
| Funahashi, Y; Nakamura, K; Taniguchi, T; Yoshimatsu, K | 1 |
| Baeksgaard, L; Sørensen, JB | 1 |
| Hosoya, Y; Kaneko, Y; Koinuma, K; Nagai, H; Saito, K; Yasuda, Y | 1 |
| Achanzar, WE; Mori, M; Nagamine, T; Qu, W; Shimoda, R; Takagi, H; Waalkes, MP | 1 |
| Adachi, W; Amano, J; Hiraguri, M; Kishimoto, K; Koide, N; Miyabayashi, H; Nakamura, T; Terai, N | 1 |
| al Rabi, N; Artibani, W; Dalpiaz, O; Ficarra, V; Galfano, A; Martignoni, G | 1 |
| Hitchcock, RJ; Mitchell, CD; Patel, Y | 1 |
| Miao, L; Wang, Y; Wu, M; Yi, P | 1 |
| Goto, H; Hanibuchi, M; Miki, T; Sone, S; Uehara, H; Yano, S; Zhang, H | 1 |
| Addicks, K; Lackner, K; Nuss, D | 1 |
| Coleman, TA; Dainer, P; Hamill, RL; Redger, CD | 1 |
| Aibe, H; Asayama, Y; Honda, H; Irie, H; Kakihara, D; Matake, K; Nakamura, K; Nakayama, T; Nishie, A; Ohga, S; Tajima, T; Yamamoto, N; Yoshimitsu, K | 1 |
| Kondo, T; Murase, K; Ozeki, Y; Shimamoto, T; Sugimoto, T | 1 |
| Ishizuka, O; Mizuno, H; Mizusawa, H; Nishizawa, O; Satoh, T; Seki, S | 1 |
| Lund, P; Niketeghad, F; Schirmacher, P; Schubert, D | 1 |
| Choi, SH; Hong, SY; Hyung, WJ; Jung, HC; Kim, KS; Lee, MH; Noh, SH; Roh, JK | 1 |
| Cook, A; Izawa, JI; Mack, DP; Moussa, M | 1 |
| Fujisawa, M; Hara, I; Kamidono, S; Kanomata, N; Kawabata, G; Kumano, Y; Takeda, M; Tanaka, K | 1 |
| deVere White, RW; Ellison, LM; Gandour-Edwards, R; Goldberg, Z; Karpman, E; Saffarian, A | 1 |
| Beaudoin, A; De Gramont, A; El Mesbahi, O; Louvet, C | 1 |
| Daneman, A; Fecteau, A; Hayes-Jordan, A; Traubici, J | 1 |
| Fukushima, T; Hirose, Y; Itoh, H; Karasawa, H; Kawabata, H; Kojima, Y; Masaki, Y; Ogawa, N; Sawaki, T; Shimoyama, K; Sugai, S; Sutoh, H; Wano, Y | 1 |
| Allen, K; Barth, NM; Beutel, LD; Chico, S; Dillman, RO; VanderMolen, LA | 1 |
| Bamias, A; Briasoulis, E; Christodoulou, C; Dimopoulos, MA; Fountzilas, G; Kalofonos, H; Kosmidis, P; Makatsoris, T; Pavlidis, N; Samantas, E; Skarlos, D | 1 |
| Amemiya, H; Asakawa, M; Fujii, H; Kono, H; Maki, A; Matsuda, M; Suzuki, T | 1 |
| Ikeda, H; Imai, K; Itoh, F; Kobayashi, T; Mita, H; Sasaki, Y; Shinomura, Y; Suzuki, H; Tokino, T; Toyota, M | 1 |
| Brodsky, I; Rosenbluth, JZ; Styler, MJ; Zak, D | 1 |
| Dai, J; Guo, Y; Jin, J; Shi, M; Wang, R; Wu, M; Zhang, X; Zhao, J | 1 |
| Aoyagi, S; Fujishita, M; Hisaka, T; Horiuchi, H; Ishikawa, H; Kawashima, Y; Kinoshita, H; Nokita, H; Shirouzu, K; Uchida, S | 1 |
| Chan, EL; Collins, MH; Emery, KH; Gelfand, MJ; Gruppo, RA; Harris, RE | 1 |
| Bjeldanes, LF; Firestone, GL; Gong, Y | 1 |
| Husain, SJ; Jamil, S; Yunus, A; Zubairi, AB | 1 |
| Amikura, T; Aoki, Y; Banzai, C; Nishikawa, N; Sekine, M; Suzuki, M; Tanaka, K; Yokoo, T | 1 |
| Dalal, BI; Kollmannsberger, C; McArthur, HL | 1 |
| Ansink, AC; Grootfaam, D; Lok, CA; ten Kate-Booij, MJ; van der Velden, J; Verheijen, RH | 1 |
| Cosse, JP; Michiels, C; Ninane, N; Piret, JP; Raes, M | 1 |
| Akaza, H; Kawai, K; Minami, M; Mori, K; Naoi, M; Shimazui, T; Takaoka, E | 1 |
| Fukumori, T; Harada, A; Hayashi, H; Izaki, H; Kanayama, HO; Kishimoto, T; Nishitani, MA; Takahashi, M; Tanimoto, S; Taue, R; Yamamoto, Y | 1 |
| Al-Asaad, TG; Al-Sulami, GA; Atra, AA; Elimam, NA; Fayea, NY; Felimban, SK; Khattab, TM | 1 |
| Mistafa, O; Roudier, E; Stenius, U | 1 |
| Ling, MT; Wang, X; Wong, YC; Zhang, X | 1 |
| Kim, DM; Lee, S; Lim, SK; Park, SY; Park, YN; Rhee, Y; Song, SY; Youn, JC | 1 |
| Horn, A; Sørbye, H; Westre, B | 1 |
| Ebisawa, S; Fujimoto, K; Hanaoka, M; Koizumi, T; Kubo, K; Tsushima, K; Urushihata, K; Yamazaki, S; Yasuo, M | 1 |
| Du, SY; Hsu, YW; Jiang, MC; Li, LT; Liao, CF; Lin, CC; Lin, CY; Luo, SF | 1 |
| Couzi, R; Holdhoff, M; Petronis, JD; Wung, PK | 1 |
| Frank, H; Fuchs, J; Heitmann, H; Herberts, T; Ruck, P; Seitz, G; Warmann, SW | 1 |
| Imai, M; Ishikawa, T; Kamimura, H; Kamimura, T; Ohta, H; Seki, K; Togashi, T; Tsuchiya, A; Watanabe, K; Yoshida, T | 1 |
| Chang, TK; Chen, HC; Chi, CS; Chou, G; Shu, SG; Wang, JD; Yang, CS | 1 |
| An, L; Han, Y; Miao, R; Wang, Q; Yang, J | 1 |
| Chang, HM; Kang, YK; Kim, KM; Kim, MK; Kim, TW; Lee, JL; Lee, JS; Lee, SS; Ryu, MH; Sym, SJ | 1 |
| Aragane, K; Furukawa, M; Horimoto, M; Hoshino, S; Kawase, I; Kijima, T; Minami, M; Okumura, M; Shiono, H; Suzuki, K | 1 |
| Hu, K; Shao, ZY; Shen, DM; Wu, F; Zhai, BJ; Zhao, CL | 1 |
| Balta, Z; Büttner, R; Fischer, HP; Hirner, A; Sauerbruch, T | 1 |
| Chau, DK; Chen, GG; Lai, PB; Miao, J; Song, G | 1 |
| Chatzimichael, A; Kalmanti, M; Katzilakis, N; Mantadakis, E; Raissaki, M; Tzardi, M | 1 |
| Chang, FY; Chao, Y; Lee, RC; Lee, SD; Lee, WP; Li, CP; Whang-Peng, J; Yen, SH; Yuan, JN | 1 |
| Hirose, S; Hojo, T; Ikeuchi, S; Isobe, Y; Kinoshita, T; Kubochi, K; Matsumoto, S; Sadako, AT; Shien, T; Terada, K | 1 |
| Melia, WM; Westaby, D; Williams, R | 1 |
| Brunner, KW; Cavalli, F; Goldhirsch, A; Joss, R; Ryssel, HJ; Sonntag, RW | 1 |
| Cavalli, F; Goldhirsch, A; Hansen, HH; Renard, J; Rozencweig, M | 1 |
| Jungi, WF | 1 |
| Johnson, PJ; Melia, WM; Williams, R | 1 |
| Bosl, GJ; Dukeman, M; Golbey, R; Herr, H; Sogani, P; Vugrin, D; Whitmore, WF; Yagoda, A | 1 |
| Hamblin, T; Loehry, CA; McCullen, M; Parham, DM; Vyas, SK; Winwood, PJ | 1 |
| Ciaccia, D; Corey, GR; Peters, W; Thel, MC; Vredenburgh, JJ | 1 |
| Gonda, T; Higuchi, T; Hirukawa, H; Hojo, I; Ishida, H; Mishima, Y; Nakajima, H | 1 |
| Castracane, VD; Hamous, J; MacLaughlin, DT; Morrow, MS; Puls, LE; Schneyer, A | 1 |
| Gabizon, AA; Gorodetsky, R; Mou, X; Vexler, AM | 1 |
| de Mulder, PH; de Pauw, M; de Wit, R; Kaye, SB; Sleijfer, DT; Spaander, PJ; Stoter, G; Sylvester, R; ten Bokkel Huinink, WW | 1 |
| Fujita, T; Hirabayashi, T; Houya, Y; Kohno, S; Masaoka, N; Matai, K; Oda, Y; Toya, N | 1 |
| Göbel, U; Harms, D; Pape, H; Spaar, HJ; Wessalowski, R; Willers, R | 1 |
| Chin, K; Hattori, T; Hayakawa, M; Maeda, H; Morise, K; Morooka, Y; Saito, H; Sugihara, M | 1 |
| Abdel-Warith, A; Abdulkareem, M; Amin, T; Ayoub, A; Ezzat, A; Fadda, M; Kagevi, I; Sieck, J; Wierzbicki, R; Yazigi, A | 1 |
| Greco, FA; Hainsworth, JD; Johnson, DH; Lamar, RE; Murphy, PB | 1 |
| Ikami, I; Kanehira, J; Kimura, T; Nishi, N; Saito, Y; Sasaki, T; Takahashi, S; Takekawa, SD; Tarusawa, K; Yodono, H | 1 |
| Gohda, E; Hamasaki, K; Namba, M; Orita, K; Seshimo, K | 1 |
| Chikamori, M; Genba, K; Ikubo, S; Kimura, I; Kiura, K; Matsumura, T; Matsuo, K; Ohnoshi, T; Tabata, M; Ueoka, H | 1 |
| Akiyama, T; Kiriyama, M; Kita, I; Kosaka, T; Nakagawa, T; Nakano, Y; Saito, H; Takano, Y; Takashima, S; Tomita, F | 1 |
| Aiba, K; Dobashi, F; Fujii, T; Funakoshi, S; Hirano, A; Inamoto, Y; Kuraishi, Y; Ogihara, A; Tada, N; Yamada, T | 1 |
| Amer, M; Bakri, YN; Ezzat, A; Jabbar, FA; Sinner, W; Subhi, J; Tweijry, A | 1 |
| Bailey, CC; Giles, GR; Heney, D; Lewis, IJ; Lockwood, L | 1 |
| Matsumoto, M; Nakae, J; Nishikawa, H; Nomiyama, T | 1 |
| Endo, Y; Hanasawa, K; Ishibashi, H; Kodama, M; Kurumi, Y; Sano, H; Shibata, J; Tani, T; Terata, N; Tsuji, K | 1 |
| Kato, M; Kinoshita, K; Matsui, H; Miyazaki, I; Sawa, T; Takano, Y; Tomita, F; Yonemura, Y; Yoshimitsu, S | 1 |
| Ganjoo, RK; Malpas, JS; Plowman, PN | 1 |
| Chen, BR; Chen, DS; Chen, YC; Cheng, AL; Chuang, SE; Yeh, KH | 1 |
| Perry, MC; Rapp, JS; Rotche, RM | 1 |
| Jones, WB; Lewis, JL; Schneider, J; Shapiro, F | 1 |
| Robinson, E; Shpendler, M; Zidan, J | 1 |
| Arakawa, H; Matsumoto, H; Morita, M; Nishimura, S; Okura, A; Sasaki, M; Taguchi, K | 1 |
| Beijnen, JH; Kuck, MT; Nooijen, WJ; Rodenhuis, S; van Tellingen, O; Vlasveld, LT | 1 |
| Fujioka, S; Kato, K; Tomono, H | 1 |
| Abo, K; Hasegawa, H; Horita, K; Nakanishi, Y; Nakashima, T; Nishisaki, H; Oya, M; Yasutake, K; Yoshida, R | 1 |
| Deguchi, S; Fujita, M; Honda, K; Kikuchi, T; Miyata, A | 1 |
| Fujimura, T; Fushida, S; Hirono, Y; Kawamura, T; Kinami, S; Minami, M; Miwa, K; Miyazaki, I; Nishimura, G; Noguchi, M; Nojima, N; Sato, T; Shiobara, S; Yonemura, Y | 1 |
| Aoki, T; Dohno, K; Gotoh, M; Higaki, N; Kishimoto, S; Monden, M; Okuyama, M; Osato, H; Sakon, M; Shimizu, J; Sugimoto, K; Takeda, H; Taniguchi, K; Umeshita, K; Yamada, T | 1 |
| Balat, O; Edwards, CL; Kavanagh, JJ; Kudelka, AP; Silva, E; Verschraegen, CF | 1 |
| Fujii, K; Fukuda, T; Hoshino, T; Ishii, T; Komatsu, M; Masamune, O; Mikami, K; Ohshima, S; Ono, T | 1 |
| Hirono, T; Hirosawa, H; Izumi, R; Kadoya, N; Konishi, I; Ohta, N; Saito, K; Ueda, N; Yoshimitsu, Y | 1 |
| Aita, P; Boiocchi, M; Robieux, I; Sorio, R; Toffoli, G | 1 |
| Adjei, PN; Gores, GJ; Kaufmann, SH; Leung, WY; Mao, F | 1 |
| Anderson, E; Anderson, T; Cameron, DA; Chetty, U; Craig, J; Dixon, M; Gabra, H; Hawkins, A; Jack, W; Kunkler, I; Lee, L; Leonard, R; Leonard, RC; MacKay, J; Matheson, L; Miller, W; Parker, AC | 1 |
| Finegold, MJ; Gunawardena, SW; Ogden, AK; Trautwein, LM | 1 |
| Ishimura, H | 1 |
| Ballard, EA; Balzer, GK; Berkow, RL; Hilliard, LM; Moertel, CL; Watterson, J | 1 |
| Drumea, K; Haim, N; Kuten, A; Moshkowitz, B; Munichor, M; Nativ, C; Stein, ME | 1 |
| Erland, JB; Greco, FA; Hainsworth, JD; Kalman, LA; Schreeder, MT | 1 |
| Cheng, AL; Chou, YY; Hsu, HC | 1 |
| Bertulezzi, G; Bobbio-Pallavicini, E; Civelli, L; Moroni, M; Nastasi, G; Porta, C; Pugliese, P | 1 |
| Lurain, JR | 1 |
| Sakata, Y; Tsushima, K | 1 |
| Ikeda, M; Ishii, H; Ito, R; Kosakamoto, H; Nakanishi, Y; Nakasuka, H; Okada, S; Okusaka, T; Sakamoto, M; Yoshimori, M | 1 |
| Fuchs, J; Haindl, J; Leuschner, I; von Schweinitz, D; Wenderoth, M | 1 |
| Asano, K; Futagami, F; Kawahara, E; Matsumura, A; Ohhori, I; Sasaki, M | 1 |
| Jobe, DR; Kuhn, J; Rizzo, J; Schreeder, MT; Walton, GD | 1 |
| Aita, P; Boiocchi, M; Cannizzaro, R; Colussi, AM; Corona, G; Robieux, I; Sorio, R; Toffoli, G; Tumolo, S | 1 |
| Hidaka, K; Kitajima, Y; Miyazaki, K; Ogawa, A; Sakamoto, Y | 1 |
| Asano, M; Higashi, S; Hosono, Y; Kane, T; Kato, C; Matsumoto, K; Sakoda, M; Sakumoto, H; Sumiyoshi, K; Takahahsi, T; Takahashi, M; Yamamoto, A | 1 |
| Aita, P; Bearz, A; Boiocchi, M; Colussi, AM; Corona, G; Sartor, F; Sorio, R; Toffoli, G | 1 |
| Bashey, A; Corringham, RE; Corringham, S; Garrett, J; Gilpin, EA; Ho, AD; Lane, TA; Law, P | 1 |
| Krcméry, V; Kunová, A | 1 |
| Lash, LH; Mathieu, P; Okafor, C; Putt, DA; Reiners, JJ | 1 |
| Barajas, MA; Peng, D; Prieto, J; Qian, C; Sun, Y | 1 |
| Anthony, LB; Drouant, G; Espanan, GD; Maloney, TJ; McCarthy, KE; Meyers, MO; Woltering, EA | 1 |
| Blanke, CD; Hemmer, MP; Witte, RS | 1 |
| Ikeda, J; Takayasu, Y; Yamamoto, S | 1 |
| Barni, S; Monaco, G; Sciola, L; Spano, A | 1 |
| Kobayashi, A; Yamaguchi, M | 1 |
| Ambros, PF; Blohm, ME; Bolkenius, M; Calaminus, G; Gnekow, AK; Göbel, U; Harms, D; Heidemann, PH; Schneider, DT; von Schweinitz, D; Weinel, P | 1 |
| Moriyama, N; Muranaka, K; Tanase, K; Tawada, M | 1 |
| Fujiwara, M; Itou, Y; Kondoh, H; Konisi, I; Tanaka, K | 1 |
| Alfieri, E; Cirillo, S; D'Amore, R; Fiorillo, A; Greco, N; Maggi, G; Marano, I; Martone, A; Migliorati, R | 1 |
| Goto, S; Okamoto, T | 1 |
| Basso, B; Boiocchi, M; Colussi, AM; Corona, G; Robieux, I; Sorio, R; Toffoli, G | 1 |
| Takayasu, Y | 1 |
| Fischer, L; Foss, HD; Koch, HC; Korfel, A; Thiel, E | 1 |
| Cooke-Yarborough, C; Martin, HC; Onikul, E; Sharathkumar, A; Shaw, PJ | 1 |
| Creamer, K; Flores, Y; Roberts, S; Robie, D; Shoupe, B | 1 |
| Aggarwal, S; Arora, A; Bhalla, S; Murthy, SA; Singh, B; Vohra, R | 1 |
| Emile, JF; Germann, N; Goldwasser, F; Gross-Goupil, M; Misset, JL; Reynes, M; Wasserman, E | 1 |
| Brunner, KW; Cavalli, F; Sonntag, RW | 1 |
| Brunner, KW; Cavalli, F; Gerber, A; Ryssel, HJ; Sonntag, RW; Tschopp, L | 1 |
| Dommann-Scherrer, C; Hassam, S; Maurer, R; Odermatt, BF; Risti, B; Zimmermann, D | 1 |
| Ikami, I; Kanehira, J; Noda, H; Sasaki, T; Shibutani, K; Shinohara, A; Takahashi, S; Takekawa, D; Tarusawa, K; Yodono, H | 1 |
| Bellman, SC; Brock, PR; Pritchard, J; Yeomans, EC | 1 |
| Midorikawa, H; Saito, Y; Sasaki, T; Takekawa, SD; Tarusawa, K; Yodono, H | 1 |
| Aoki, K; Nose, H; Okada, S; Okazaki, N; Yoshimori, M | 1 |
| Calne, R; Clark, PI; Owen, RA; Stebbings, W; Whelan, JS | 1 |
| Fushida, S; Kaji, M; Kosaka, T; Matsumoto, H; Muraoka, K; Nakai, M; Segawa, M; Takano, Y; Tsugawa, K; Yonemura, Y | 1 |
| Fukushima, W; Hirosawa, H; Kadoya, N; Konishi, K; Kuroda, Y; Sahara, H; Saitoh, F; Taniya, T; Tsuji, M; Yabushita, K | 1 |
| Shiu, WC | 1 |
| Bandou, H; Kobayashi, T; Mura, T; Nomura, T; Watanabe, K | 1 |
| Gotoda, A; Kamiyama, T; Matsuoka, S; Nagabuchi, E; Nakajima, Y; Saito, M; Uchino, J; Une, Y | 1 |
| Atikachai, B; Jiemsripong, K; Phothirat, C; Thongprasert, S | 1 |
| Bagshawe, KD; Begent, RH; Bradley, J; Dawson, PM; Kulkarni, RP; Makey, AR; Newlands, ES; Reynolds, KW; Rustin, GJ; Theodorou, NA | 1 |
| Cantwell, B; Fossà, SD; Harding, MJ; Jones, WG; Lewis, CR; Mead, G; Mill, L; Paul, J; Rodenburg, CJ; ten Bokkel Huinink, W | 1 |
| Furukawa, H; Hara, T; Hoshino, K; Taniguchi, T | 1 |
| Gearhart, JP; Jeffs, RD; Leonard, MP | 1 |
| Ohtagaki, S; Toge, T; Toi, M; Yagi, M; Yoshinaka, K | 1 |
| Adachi, J; Misumi, S; Ohye, C; Ono, N; Tamura, M | 1 |
| Hasegawa, Y; Honnma, S; Nakashima, Y; Takanashi, K; Yajima, K | 1 |
| Fujita, M; Imaoka, S; Inoue, A; Ishiguro, S; Kasugai, H; Kojima, J; Okuda, S; Sasaki, Y; Shibata, K | 1 |
| Hayashi, K; Ito, T; Sugino, N; Yakabe, A; Yamashita, S | 1 |
| Fujii, I; Hayashi, S; Kohlita, Y | 1 |
| Flora, G; Grunberg, SM; Sharma, D | 1 |
| Akimura, R; Fujii, N; Ikami, I; Kanehira, J; Kimura, T; Midorikawa, H; Nakamura, Y; Sasaki, T; Tarusawa, K; Yodono, H | 1 |
| Fujino, H; Tagawa, K; Unuma, T; Yasuda, H | 1 |
| Izumi, R; Kobayashi, K; Matsui, O; Miyazaki, I; Shimizu, K; Watanabe, T | 1 |
| Bernard, JP; Brune, J; Champel, F; Chauvin, F; Clavel, M; Cordier, JF; Emonot, A; Guérin, JC; Kalb, JC; Trillet, V | 1 |
| Bacchi, M; Bassi, P; Belsanti, V; Bisagni, G; Boni, C; Cocconi, G; Lottici, R; Passalacqua, R; Tonato, M | 1 |
| Bosman, C; Ceccamea, A; Clerico, A; De Sanctis, S; Dominici, C; Thorel, MF | 1 |
| Daniels, M; Estape, J; Gardella, S; Grau, JJ; Santabarbara, P; Viñolas, N | 1 |
| Hashimoto, N; Hayashi, S; Kanda, Y; Miki, M; Oda, H; Okazaki, N; Sasagawa, Y; Yoshida, T; Yoshino, M | 1 |
| Anas, N; Cairo, MS; Sender, L; Siegel, S | 1 |
| Kanehira, J; Kimura, T; Nakamura, Y; Nishi, N; Saito, Y; Sasaki, T; Takahashi, S; Takekawa, S; Tarusawa, K; Yodono, H | 1 |
| Adachi, M; Fujii, S; Nakajima, K; Sugai, Y; Ueno, K | 1 |
| Kimura, K; Niitani, H; Yamada, K | 1 |
| Choo, YC; Ma, HK; Wong, LC | 1 |
| Bennett, M; Buamah, PK; James, OF; Lendrum, R; McArdle, P | 1 |
| Bonardi, G; Calciati, A; Donadio, M; Giaccone, G; Leria, G | 1 |
| Budd, GT; Coltman, CA; Crowley, JP; Grever, MR; Harker, G; Livingston, RB; Mira, JG; Rivkin, SE; Schulman, S; Vogel, S | 1 |
| Leung, N; Li, A; Li, M; Martin, C; Mok, SD; Shiu, W; Zacharia, A | 1 |
| Furusawa, A; Hattori, N; Hirai, N; Izumi, R; Kato, Y; Kobayashi, K; Matsui, O; Shimoda, A; Tanaka, N; Unoura, M | 1 |
| Achterrath, W; Fink, U; Meyer, HJ; Meyer, J; Neuhaus, P; Preusser, P; van de Loo, J; Wilke, H | 1 |
25 review(s) available for etoposide and Liver Neoplasms
| Article | Year |
|---|---|
Mixed Primary Hepatocellular Carcinoma and Hepatic Neuroendocrine Carcinoma: Case Report and Literature Review.
Topics: Carcinoma, Hepatocellular; Carcinoma, Neuroendocrine; Etoposide; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local | 2023 |
Neuroendocrine small cell rectal cancer metastasizing to the liver: a unique treatment strategy, case report, and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Liver Neoplasms; Male; Middle Aged; Prognosis; Rectal Neoplasms; Review Literature as Topic; Somatostatin; Tomography, X-Ray Computed | 2013 |
Role of High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Men With Previously Treated Germ Cell Tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Complex and Mixed; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Testicular Neoplasms; Transplantation, Autologous | 2017 |
[A case of alpha-fetoprotein-producing gastric cancer with hepatic metastasis successfully treated with combination chemotherapy].
Topics: Adenocarcinoma; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Stomach Neoplasms | 2008 |
[Clinical characteristics and treatment of desmoplastic small round cell tumor].
Topics: Abdominal Neoplasms; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Desmoplastic Small Round Cell Tumor; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prostatic Neoplasms; Radiotherapy, Conformal; Surgical Procedures, Operative; Survival Rate; Vincristine; Young Adult | 2010 |
[Case of primary hepatic neuroendocrine carcinoma diagnosed by needle biopsy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma, Neuroendocrine; Carcinoma, Transitional Cell; Cisplatin; Diagnosis, Differential; Diagnostic Imaging; Etoposide; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Urinary Bladder Neoplasms | 2010 |
Malignant perivascular epithelioid cell tumor in children: description of a case and review of the literature.
Topics: Abdominal Neoplasms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biopsy; Child, Preschool; Combined Modality Therapy; Diagnostic Errors; Etoposide; Female; Humans; Imatinib Mesylate; Intestinal Obstruction; Ligaments; Liver Neoplasms; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Perivascular Epithelioid Cell Neoplasms; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Radiography; Sarcoma, Clear Cell; Sirolimus; X Chromosome Inactivation | 2012 |
Primary focal T-cell lymphoma of the liver: a case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Liver Neoplasms; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Prednisone; Tomography, X-Ray Computed; Vincristine | 2012 |
Desmoplastic small round cell tumour: a description of two cases and review of the literature.
Topics: Abdominal Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Humans; Liver Neoplasms; Male; Prognosis; Salvage Therapy | 2003 |
Small cell carcinoma of the bladder: a case report and a literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Life Tables; Liver Neoplasms; Male; Middle Aged; Stevens-Johnson Syndrome; Survival Analysis; Urinary Bladder Neoplasms; Vincristine | 2003 |
Oncocytic adrenocortical carcinoma.
Topics: Adenocarcinoma; Adrenal Cortex Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Embolization, Therapeutic; Etoposide; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mitotane; Nephrectomy; Ribs; Tomography, X-Ray Computed | 2004 |
Analysis of treatment for small cell cancer of the bladder and report of three cases.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Biomarkers, Tumor; Bone Neoplasms; Carboplatin; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Deoxycytidine; Disease Progression; Etoposide; Gemcitabine; Humans; Life Tables; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasms, Second Primary; Prostatectomy; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Urinary Diversion | 2004 |
Combination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Cisplatin; Combined Modality Therapy; Deoxycytidine; Doxorubicin; Etoposide; Femoral Neoplasms; Gemcitabine; Head and Neck Neoplasms; Humans; Ifosfamide; Irinotecan; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Palliative Care; Salvage Therapy; Scalp; Skin Neoplasms; Thoracotomy | 2005 |
Favorable histology, MYCN-amplified 4S neonatal neuroblastoma.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gene Amplification; Genes, myc; Genes, Neoplasm; Hepatomegaly; Humans; Infant, Newborn; Isotretinoin; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Neuroblastoma; Prognosis; Remission Induction; Risk Factors | 2007 |
[Etoposide. A new highly effective cytostatic agent in anaplastic small-cell bronchial carcinoma, other solid tumors and hemoblastoses].
Topics: Bronchial Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Small Cell; Cell Division; Choriocarcinoma; Etoposide; Female; Humans; Leukemia; Liver Neoplasms; Lung Neoplasms; Male; Ovarian Neoplasms; Podophyllotoxin; Pregnancy; Testicular Neoplasms; Uterine Neoplasms | 1981 |
Management of high-risk gestational trophoblastic disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Dactinomycin; Etoposide; Female; Folic Acid; Humans; Liver Neoplasms; Methotrexate; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1998 |
[Treatment of recurrent gastric cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Fluorouracil; Humans; Immunologic Factors; Irinotecan; Liver Neoplasms; Lymphatic Metastasis; Methotrexate; Mitomycin; Neoplastic Cells, Circulating; Peritoneal Neoplasms; Stomach Neoplasms | 1998 |
Disseminated choriocarcinoma in infancy is curable by chemotherapy and delayed tumour resection.
Topics: Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chromosome Aberrations; Cisplatin; Diseases in Twins; Etoposide; Female; Humans; Ifosfamide; Immunohistochemistry; In Situ Hybridization, Fluorescence; Infant; Liver Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Scapula; Shoulder Joint; Time Factors | 2001 |
[Intra-arterial infusion chemotherapy for liver metastases of testicular tumors: report of two cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Embryonal; Choriocarcinoma; Cisplatin; Etoposide; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Seminoma; Testicular Neoplasms; Treatment Outcome; Vinblastine | 2000 |
[A case of small cell carcinoma of the pancreas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Liver Neoplasms; Middle Aged; Pancreatic Neoplasms; Phosphopyruvate Hydratase | 2001 |
[Hepatic arterial infusion chemotherapy for hepatocellular carcinoma by EEP regimen].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheters, Indwelling; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Treatment Outcome | 2001 |
Unique management of stage 4S neuroblastoma complicated by massive hepatomegaly: case report and review of the literature.
Topics: Abdominal Muscles; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Breast Feeding; Carboplatin; Combined Modality Therapy; Enteral Nutrition; Etoposide; Hemorrhage; Hepatomegaly; Humans; Infant; Laparotomy; Liver Neoplasms; Lung Diseases; Male; Neoplasm Staging; Neuroblastoma; Occlusive Dressings; Pancytopenia; Parenteral Nutrition, Total; Positive-Pressure Respiration; Postoperative Complications; Sepsis; Surgical Mesh; Vacuum | 2002 |
[Multiple liver metastases of a suprasellar germ cell tumor treated with combined chemotherapy of cisplatin and etoposide].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dysgerminoma; Etoposide; Humans; Liver Neoplasms; Male; Pituitary Neoplasms; Remission Induction | 1991 |
Chemotherapy of metastatic Merkel cell carcinoma: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Merkel Cell; Cisplatin; Etoposide; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Skin Neoplasms | 1991 |
[Small cell lung carcinoma. Value of the evaluation of extension for the therapeutic strategy].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Prognosis; Prospective Studies; Spinal Cord Neoplasms | 1990 |
26 trial(s) available for etoposide and Liver Neoplasms
| Article | Year |
|---|---|
A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Docetaxel; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids | 2010 |
Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Small Cell; Cisplatin; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Prostatic Neoplasms; Survival Analysis; Treatment Outcome | 2002 |
Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Etoposide; Female; Fluorouracil; Hepatoblastoma; Humans; Infant; Infant, Newborn; Liver Neoplasms; Male; Neoplasm Metastasis; Survival Rate; Vincristine | 2002 |
High-dose chemotherapy and autologous stem cell rescue for metastatic breast cancer: superior survival for tandem compared with single transplants.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carboplatin; Cohort Studies; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Middle Aged; Mitoxantrone; Organ Specificity; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Survival Analysis; Thiotepa; Transplantation, Autologous; Treatment Outcome | 2005 |
Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Camptothecin; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Irinotecan; Liver Neoplasms; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Survival Analysis | 2005 |
Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a p
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Chemotherapy, Cancer, Regional Perfusion; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Portal Vein; Prospective Studies; Severity of Illness Index; Tablets, Enteric-Coated; Tegafur; Time Factors; Treatment Outcome; Uracil; Venous Thrombosis | 2007 |
Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged | 2008 |
Induction of remission in hepatocellular carcinoma. A comparison of VP 16 with adriamycin.
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Doxorubicin; Etoposide; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pilot Projects; Podophyllotoxin; Prognosis; Random Allocation | 1983 |
Reduction of the systemic toxicity of cisplatin by intra-arterial hepatic route administration for liver malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Kidney Diseases; Leucovorin; Liver; Liver Neoplasms; Methotrexate; Neoplasms; Nervous System Diseases; Ovarian Neoplasms; Remission Induction; Spectrophotometry, Atomic; Tumor Cells, Cultured; Vinblastine | 1995 |
Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Prognosis; Survival Rate; Testicular Neoplasms; Time Factors; Vinblastine | 1995 |
Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Stomach Neoplasms; Survival Analysis; Tegafur; Uracil | 1994 |
Phase II trial of chronic daily VP-16 administration in unresectable hepatocellular carcinoma (HCC).
Topics: Administration, Oral; Adult; Aged; Carcinoma, Hepatocellular; Drug Administration Schedule; Etoposide; Female; Humans; Liver Neoplasms; Male; Middle Aged | 1994 |
Chronic oral etoposide and tamoxifen in the treatment of far-advanced hepatocellular carcinoma.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Administration Schedule; Etoposide; Female; Humans; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Tamoxifen | 1996 |
High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Central Nervous System Neoplasms; Chi-Square Distribution; Confidence Intervals; Diarrhea; Disease-Free Survival; Etoposide; Female; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Herpes Zoster; Humans; Liver Neoplasms; Lung Neoplasms; Melphalan; Middle Aged; Neoplasm Staging; Survival Rate; Thiotepa; Treatment Outcome | 1996 |
Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide.
Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Etoposide; Female; Humans; Liver Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Survival Analysis | 1997 |
Epirubicin and etoposide combination chemotherapy to treat hepatocellular carcinoma patients: a phase II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Survival Analysis; Survival Rate; Treatment Outcome | 1997 |
[Arterial infusion therapy with implantable port for inoperable hepatobiliary tumors].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Cisplatin; Colonic Neoplasms; Drug Administration Schedule; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Stomach Neoplasms | 1999 |
Pharmacokinetic interaction between etoposide and tamoxifen in patients with hepatocellular carcinoma.
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma, Hepatocellular; Drug Interactions; Etoposide; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Protein Binding; Tamoxifen; Time Factors | 1999 |
A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carboplatin; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Liver Neoplasms; Middle Aged; Mitoxantrone; Platelet Count; Soft Tissue Neoplasms; Survival Rate; Tamoxifen; Thiotepa; Transplantation, Autologous | 2000 |
Population pharmacokinetics and pharmacodynamics of oral etoposide.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Area Under Curve; Biological Availability; Breast Neoplasms; Creatinine; Cross-Over Studies; Etoposide; Female; Humans; Injections, Intravenous; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Models, Biological; Software; Stomach Neoplasms | 2001 |
Treatment of small cell lung cancer: experience at Maharaj Nakhon Chiang Mai Hospital.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Thailand; Vincristine | 1991 |
BOP/VIP--a new platinum-intensive chemotherapy regimen for poor prognosis germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Brain Neoplasms; Chorionic Gonadotropin; Cisplatin; Creatinine; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Liver Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Remission Induction; Survival Analysis; Vincristine | 1991 |
[Small cell lung carcinoma. Value of the evaluation of extension for the therapeutic strategy].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Prognosis; Prospective Studies; Spinal Cord Neoplasms | 1990 |
Clinical trial of continuous infusion verapamil, bolus vinblastine, and continuous infusion VP-16 in drug-resistant pediatric tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Child; Child, Preschool; Clinical Trials as Topic; Etoposide; Humans; Infusions, Intravenous; Leukemia; Liver Neoplasms; Neuroblastoma; Verapamil; Vinblastine | 1989 |
[Phase I clinical study of NK 171 (etoposide)].
Topics: Administration, Oral; Adult; Aged; Carcinoma, Hepatocellular; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Podophyllotoxin | 1985 |
Combined alkylators and multiple-site irradiation for extensive small cell lung cancer: a Southwest Oncology Group Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Hematologic Diseases; Humans; Liver Neoplasms; Lung Neoplasms; Random Allocation | 1986 |
253 other study(ies) available for etoposide and Liver Neoplasms
| Article | Year |
|---|---|
Design and synthesis of novel 4'-demethyl-4-deoxypodophyllotoxin derivatives as potential anticancer agents.
Topics: Animals; Antineoplastic Agents; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Drug Design; Drugs, Chinese Herbal; G2 Phase Cell Cycle Checkpoints; Hep G2 Cells; Humans; Liver Neoplasms; M Phase Cell Cycle Checkpoints; Mice; Mice, Nude; Podophyllotoxin; Transplantation, Heterologous | 2016 |
Synthesis and biological evaluation of cyclopeptide GG-8-6 and its analogues as anti-hepatocellular carcinoma agents.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Female; G2 Phase Cell Cycle Checkpoints; Hep G2 Cells; Humans; Liver Neoplasms; M Phase Cell Cycle Checkpoints; Mice; Mice, Inbred BALB C; Mice, Nude; Peptides, Cyclic; Protein Structure, Tertiary; Structure-Activity Relationship; Transplantation, Heterologous | 2018 |
Design, synthesis and anti-hepatocellular carcinoma activity of 3-arylisoquinoline alkaloids.
Topics: Alkaloids; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Isoquinolines; Liver Neoplasms; Molecular Structure; Structure-Activity Relationship | 2022 |
Design, synthesis and biological evaluation of 3-arylisoquinoline derivatives as topoisomerase I and II dual inhibitors for the therapy of liver cancer.
Topics: Alkaloids; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Design; Humans; Isoquinolines; Liver Neoplasms; Molecular Docking Simulation; Phosphatidylinositol 3-Kinases; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2022 |
Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation.
Topics: Child, Preschool; Cord Blood Stem Cell Transplantation; Cyclin-Dependent Kinase Inhibitor p16; Cyclophosphamide; Cytarabine; DNA-Binding Proteins; Etoposide; ETS Translocation Variant 6 Protein; Female; Gene Deletion; Humans; Liver Neoplasms; Lymphoma, T-Cell; PAX5 Transcription Factor; Prognosis; Proto-Oncogene Proteins c-ets; Remission Induction; Repressor Proteins; Splenic Neoplasms; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2022 |
A 33-Year-Old Man With Chest Pain.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Carboplatin; Carcinoma; Etoposide; Fatal Outcome; Gene Rearrangement; Humans; Liver Failure; Liver Neoplasms; Lung Neoplasms; Lymphadenopathy; Male; Neoplasm Proteins; Nuclear Proteins; Positron-Emission Tomography; Tomography, X-Ray Computed; Transcription Factors; Tumor Lysis Syndrome | 2022 |
Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front-line chemotherapy regimens.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Liver Neoplasms; Paclitaxel; Platinum; Retrospective Studies; Thymoma; Thymus Neoplasms | 2022 |
Anlotinib plus platinum-etoposide as a first-line treatment for extensive-stage small cell lung cancer: A single-arm trial.
Topics: Brain Neoplasms; Etoposide; Humans; Indoles; Liver Neoplasms; Lung Neoplasms; Platinum; Quinolines; Small Cell Lung Carcinoma | 2022 |
Antitumor Effect of
Topics: Antineoplastic Agents; Boraginaceae; Carcinoma, Hepatocellular; DNA Topoisomerases, Type II; Etoposide; Humans; Leukemia, Myeloid, Acute; Liver Neoplasms; Naphthoquinones; Oils, Volatile; Reactive Oxygen Species; Topoisomerase II Inhibitors | 2022 |
Evaluation of Lung and Liver Tumor Dose Coverage Treated With the CyberKnife Synchrony System With Consideration of Measured Tracking Errors.
Topics: Etoposide; Humans; Liver Neoplasms; Lung; Lung Neoplasms; Phantoms, Imaging; Radiosurgery; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Respiration | 2023 |
Antitumor activity of bovine lactoferrin and its derived peptides against HepG2 liver cancer cells and Jurkat leukemia cells.
Topics: Child; Cisplatin; Etoposide; Hep G2 Cells; Humans; Jurkat Cells; Lactoferrin; Liver Neoplasms; Necrosis; Peptides; Quality of Life | 2023 |
Clinical impact of first-line PD-1 or PD-L1 inhibitors combined with chemotherapy in extensive-stage small cell lung cancer patients: A real-world multicenter propensity score-matched study.
Topics: Etoposide; Humans; Immune Checkpoint Inhibitors; Liver Neoplasms; Lung Neoplasms; Platinum; Programmed Cell Death 1 Receptor; Propensity Score; Small Cell Lung Carcinoma | 2023 |
Components of the JNK-MAPK pathway play distinct roles in hepatocellular carcinoma.
Topics: Anisomycin; Apoptosis; Carcinoma, Hepatocellular; Etoposide; Humans; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; MAP Kinase Kinase 7; Tumor Necrosis Factor-alpha | 2023 |
Individualized chemotherapy and efficacy analysis of hepatoblastoma in children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cisplatin; Cyclophosphamide; Etoposide; Hepatoblastoma; Humans; Ifosfamide; Liver Neoplasms; Vincristine | 2024 |
High Dose Chemotherapy with Autologous Stem Cell Transplantation in Hepatoblastoma does not Improve Outcome. Results of the GPOH Study HB99.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hepatoblastoma; Humans; Ifosfamide; Liver Neoplasms; Neoplasm Recurrence, Local; Transplantation, Autologous; Treatment Outcome | 2019 |
Partial response to carboplatin, etoposide phosphate, and atezolizumab in a pediatric patient with high-grade metastatic tumor with rhabdoid and focal neuroendocrine features.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Etoposide; Humans; Liver Neoplasms; Male; Neoplasm Grading; Neuroendocrine Tumors; Organophosphorus Compounds; Rhabdoid Tumor; Treatment Outcome | 2020 |
Computed Tomography and Magnetic Resonance Imaging in the Diagnosis of Primary Neuroendocrine Tumors of the Liver.
Topics: Ablation Techniques; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Carcinoma, Neuroendocrine; Chemoembolization, Therapeutic; Cisplatin; Etoposide; Female; Hepatectomy; Humans; Liver Neoplasms; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Neuroendocrine Tumors; Octreotide; Tomography, X-Ray Computed | 2020 |
Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carcinoma, Hepatocellular; Etoposide; Female; Germany; Humans; Ifosfamide; Kaplan-Meier Estimate; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mitoxantrone; Neoplasm Staging; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Assessment; ROC Curve; Tomography, X-Ray Computed; Young Adult | 2020 |
Successful treatment of hepatosplenic T cell lymphoma in an adolescent with Turner syndrome using ifosfamide, carboplatin, and etoposide followed by allogeneic hematopoietic stem cell transplant.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Liver Neoplasms; Lymphoma, T-Cell; Prognosis; Splenic Neoplasms; Turner Syndrome | 2020 |
Hyperthermic intraperitoneal chemotherapy (HIPEC) as another treatment modality for desmoplastic round cell tumour patients: first paediatric experience from UK.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Cyclophosphamide; Cytoreduction Surgical Procedures; Desmoplastic Small Round Cell Tumor; Doxorubicin; Etoposide; Female; Humans; Hyperthermic Intraperitoneal Chemotherapy; Ifosfamide; Liver Neoplasms; Maintenance Chemotherapy; Neoadjuvant Therapy; Pelvic Neoplasms; Peritoneal Neoplasms; Radiotherapy; Remission Induction; United Kingdom; Vincristine; Vinorelbine | 2021 |
Dual-modified albumin-polymer nanocomplexes with enhanced in vivo stability for hepatocellular carcinoma therapy.
Topics: Albumins; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Etoposide; Liver Neoplasms; Mice; Nanoparticles; Polymers | 2021 |
Case Report: Ectopic Adrenocortical Carcinoma in the Ovary.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Antineoplastic Agents; Bevacizumab; Cisplatin; Cytoreduction Surgical Procedures; Etoposide; Female; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Ovary | 2021 |
[Conversion Therapy Using Etoposide and Cisplatin Chemotherapy for Liver Metastases from Advanced Gastric Mixed Adenoneuroendocrine Carcinoma - A Case Report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Liver Neoplasms; Male; Middle Aged; Stomach Neoplasms | 2017 |
Successful chemotherapeutic treatment for metastatic littoral cell angioma: A case report.
Topics: Antineoplastic Agents, Phytogenic; Biopsy; Cytotoxins; Etoposide; Female; Fluorodeoxyglucose F18; Hemangioma; Humans; Immunohistochemistry; Liver; Liver Neoplasms; Middle Aged; Paclitaxel; Positron-Emission Tomography; Radiopharmaceuticals; Splenectomy; Splenic Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2018 |
Corylin increases the sensitivity of hepatocellular carcinoma cells to chemotherapy through long noncoding RNA RAD51-AS1-mediated inhibition of DNA repair.
Topics: Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; DNA Repair; Etoposide; Flavonoids; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; RNA, Long Noncoding; RNA, Neoplasm | 2018 |
Dramatic response of nivolumab-associated psoriasiform dermatitis to etoposide.
Topics: Antineoplastic Agents, Immunological; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Dermatitis; Etoposide; Humans; Liver Neoplasms; Male; Middle Aged; Nivolumab; Prognosis; Psoriasis | 2019 |
The clinical conundrum of managing relapsed small cell lung cancer.
Topics: Anthracyclines; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepinones; Carboplatin; Clinical Decision-Making; Disease Progression; Etoposide; Humans; Immunoconjugates; Irinotecan; Liver Neoplasms; Lung Neoplasms; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Nivolumab; Paclitaxel; Piperazines; Pyrimidines; Salvage Therapy; Small Cell Lung Carcinoma; Temozolomide; Thiourea; Topotecan | 2019 |
A Neuroendocrine Tumor of Unknown Primary Origin that Responded to Treatment Based on Tumor Grade Progression.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Hormones; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Somatostatin; Treatment Outcome | 2019 |
PRRX1 isoforms cooperate with FOXM1 to regulate the DNA damage response in pancreatic cancer cells.
Topics: Animals; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; DNA Damage; DNA Repair; Epithelial-Mesenchymal Transition; Etoposide; Forkhead Box Protein M1; Gemcitabine; HEK293 Cells; Homeodomain Proteins; Humans; Liver Neoplasms; Mice; Mice, Knockout; Pancreas; Pancreatic Neoplasms; Protein Isoforms; Transcription, Genetic | 2019 |
Stage 4S Neuroblastoma: A Report of Two Cases Presenting with Extremes of Biological Behavior.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Infant; Infant, Newborn; Liver Neoplasms; Male; Neoplasm Staging; Neuroblastoma; Treatment Outcome | 2019 |
Sustained Remission After Maintenance Irinotecan in Patient With Multiply Relapsed Hepatoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chemotherapy, Adjuvant; Disease-Free Survival; Etoposide; Hepatoblastoma; Humans; Ifosfamide; Infant; Irinotecan; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Remission Induction | 2020 |
Etoposide dosage adjustment in two patients with neuroendocrine tumors and severe liver impairment.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Etoposide; Fatal Outcome; Female; Humans; Liver Neoplasms; Middle Aged; Neuroendocrine Tumors; Severity of Illness Index | 2020 |
Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Diagnosis, Differential; Etoposide; Female; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Prognosis; Review Literature as Topic | 2013 |
HIF1 regulates WSB-1 expression to promote hypoxia-induced chemoresistance in hepatocellular carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Carrier Proteins; Cell Hypoxia; DNA Damage; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Proteins; RNA Interference; RNA, Small Interfering; Tetrazolium Salts; Thiazoles | 2013 |
Protein phosphatase 2A promotes hepatocellular carcinogenesis in the diethylnitrosamine mouse model through inhibition of p53.
Topics: Animals; Biopsy; Carcinoma, Hepatocellular; Diethylnitrosamine; Disease Models, Animal; Etoposide; Gene Expression Regulation, Enzymologic; Hepacivirus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Mice; Mice, Inbred C57BL; Mice, Transgenic; Organophosphorus Compounds; Phosphorylation; Protein Phosphatase 2; Tumor Suppressor Protein p53 | 2014 |
An exceptional case of atrial fibrillation arrhythmia induced by etoposide.
Topics: Antineoplastic Agents, Phytogenic; Atrial Fibrillation; Drug Monitoring; Etoposide; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms | 2013 |
Synergistic anti-proliferative effect of resveratrol and etoposide on human hepatocellular and colon cancer cell lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Synergism; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Resveratrol; Stilbenes; Tumor Suppressor Protein p53 | 2013 |
Hepatitis B virus inhibits apoptosis of hepatoma cells by sponging the MicroRNA 15a/16 cluster.
Topics: Adult; Aged; Animals; Antiviral Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Down-Regulation; Etoposide; Female; Hepatitis B virus; Host-Pathogen Interactions; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; MicroRNAs; Middle Aged; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; RNA, Viral | 2013 |
Fertility-sparing surgery for advanced juvenile granulosa cell tumor of the ovary.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytoreduction Surgical Procedures; Diaphragm; Etoposide; Female; Fertility Preservation; Granulosa Cell Tumor; Humans; Liver Neoplasms; Omentum; Organ Sparing Treatments; Recurrence; Splenic Neoplasms | 2014 |
Activity of the polyamine-vectorized anti-cancer drug F14512 against pediatric glioma and neuroblastoma cell lines.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Cell Survival; Cisplatin; Etoposide; Female; Glioma; Humans; Liver Neoplasms; Melphalan; Mice, Inbred BALB C; Neuroblastoma; Podophyllotoxin; Radiation, Ionizing; Spermine | 2014 |
Chemoresponsive liver hemangioma in a patient with metastatic malignant teratoma.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Etoposide; Hemangioma; Humans; Incidental Findings; Liver Neoplasms; Male; Neoplasms, Multiple Primary; Remission Induction; Teratoma; Testicular Neoplasms; Tomography, X-Ray Computed | 2015 |
Tumor lysis syndrome in a nonsmall cell lung cancer.
Topics: Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Fatal Outcome; Female; Humans; Liver Neoplasms; Lung Neoplasms; Tumor Lysis Syndrome | 2014 |
Sorafenib overcomes the chemoresistance in HBx-expressing hepatocellular carcinoma cells through down-regulation of HBx protein stability and suppresses HBV gene expression.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma, Hepatocellular; Cisplatin; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Viral; Hep G2 Cells; Hepatitis B virus; Humans; Interferon-alpha; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Promoter Regions, Genetic; Proteasome Endopeptidase Complex; Protein Stability; Sorafenib; Trans-Activators; Transfection; Viral Regulatory and Accessory Proteins | 2014 |
Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Choriocarcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hysterectomy; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Remission Induction; Retrospective Studies; Risk Factors; Salvage Therapy; Survival Rate; Uterine Neoplasms; Vaginal Neoplasms; Vincristine; Young Adult | 2015 |
Resistance of SMMC-7721 hepatoma cells to etoposide in hypoxia is reversed by VEGF inhibitor.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Hypoxia; Cell Line, Tumor; Drug Resistance, Neoplasm; Etoposide; Extracellular Signal-Regulated MAP Kinases; Humans; Hypoxia; Liver Neoplasms; NF-kappa B; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Vascular Endothelial Growth Factor A | 2015 |
MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Etoposide; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; MicroRNAs; Molecular Targeted Therapy; Niacinamide; Paclitaxel; Phenylurea Compounds; Protein Kinase Inhibitors; PTEN Phosphohydrolase; Sorafenib | 2015 |
Reptin regulates DNA double strand breaks repair in human hepatocellular carcinoma.
Topics: Antineoplastic Agents, Phytogenic; Ataxia Telangiectasia Mutated Proteins; ATPases Associated with Diverse Cellular Activities; Blotting, Western; Carcinoma, Hepatocellular; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Comet Assay; DNA Breaks, Double-Stranded; DNA Helicases; DNA Repair; DNA-Activated Protein Kinase; Etoposide; Gamma Rays; Histones; Humans; Liver Neoplasms; Microscopy, Confocal; Nuclear Proteins; Phosphorylation; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference | 2015 |
A hyposensitive anticancer drug induces higher surface expression and release of heat shock proteins in a human hepatocellular carcinoma cell line.
Topics: Antineoplastic Agents; Apoptosis; Carboplatin; Carcinoma, Hepatocellular; Enzyme-Linked Immunosorbent Assay; Etoposide; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; Hep G2 Cells; HSP70 Heat-Shock Proteins; Humans; Liver Neoplasms; Membrane Glycoproteins; Microscopy, Fluorescence; RNA, Messenger | 2015 |
Diffuse large B-cell lymphoma causing acute liver failure: a rare case of survival.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Humans; Liver Failure, Acute; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Invasiveness; Prednisone; Treatment Outcome; Vincristine | 2015 |
Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Cisplatin; Etoposide; Female; France; Gestational Trophoblastic Disease; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Middle Aged; Mortality; Pregnancy; Prognosis; Retrospective Studies; Risk Factors; Severity of Illness Index; Time Factors; Young Adult | 2016 |
[Radical surgery after successful chemotherapy in a case of primary small cell carcinoma of the liver].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Liver Neoplasms; Middle Aged | 2015 |
Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Inhibitory Concentration 50; Liver Neoplasms; Male; Mice, SCID; MicroRNAs; Niacinamide; Paclitaxel; Phenylurea Compounds; Protein Kinase Inhibitors; Quercetin; Receptor, Notch1; Signal Transduction; Sorafenib; Transfection; Xenograft Model Antitumor Assays | 2016 |
Multi-Target Approach to Metastatic Adrenal Cell Carcinoma.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Laparotomy; Liver Neoplasms; Mitotane; Positron Emission Tomography Computed Tomography | 2016 |
Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Clinical Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Hepatoblastoma; Humans; Ifosfamide; Infant; Liver Neoplasms; Male; Neoadjuvant Therapy; Prognosis; Treatment Outcome | 2016 |
A Case of Endoscopically Complete Remission of Esophageal Neuroendocrine Tumors by Concurrent Chemoradiation Therapy.
Topics: Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Chemoradiotherapy; Chromogranin A; Cisplatin; Esophageal Neoplasms; Esophagoscopy; Etoposide; Female; Humans; Liver Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Synaptophysin | 2016 |
[Recurrent Gastric Carcinoma(Endocrine Cell Type)Successfully Treated with Multidisciplinary Therapy - A Case Report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Etoposide; Female; Gastrectomy; Hepatectomy; Humans; Liver Neoplasms; Lung Neoplasms; Recurrence; Stomach Neoplasms | 2016 |
An attempt to evaluate the effect of vitamin K3 using as an enhancer of anticancer agents.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Proliferation; Cyclins; Drug Synergism; Enzyme Inhibitors; Etoposide; Flow Cytometry; G2 Phase; Humans; Indicators and Reagents; Liver Neoplasms; Topoisomerase II Inhibitors; Vitamin K 3 | 2008 |
[Features of clinical course of combination chemotherapy for liver involvement in Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Liver Neoplasms; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prognosis; Radionuclide Imaging; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Vinblastine; Vincristine | 2008 |
Sexual precocity associated with an abdominal tumor in an African boy.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Child, Preschool; Chorionic Gonadotropin; Cisplatin; Etoposide; Hepatectomy; Hepatoblastoma; Humans; Liver Neoplasms; Male; Puberty, Precocious; Treatment Outcome | 2008 |
Gestational trophoblastic tumor with liver metastasis after misoprostol abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Liver Neoplasms; Methotrexate; Misoprostol; Pregnancy; Uterine Neoplasms; Vincristine | 2009 |
Reduction in the size of a hepatic haemangioma after chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Endodermal Sinus Tumor; Etoposide; Female; Hemangioma; Humans; Hysterectomy; Liver Neoplasms; Magnetic Resonance Imaging; Neoplasms, Multiple Primary; Ovarian Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
[Efficacy of chemotherapy combined hyperfractionated accelerated radiotherapy on limited small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Dose Fractionation, Radiation; Esophagitis; Etoposide; Female; Follow-Up Studies; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiation Pneumonitis; Radiotherapy, High-Energy; Remission Induction; Small Cell Lung Carcinoma; Survival Rate | 2008 |
Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma.
Topics: Adrenal Gland Neoplasms; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Fluorouracil; Focal Nodular Hyperplasia; Granulocyte Colony-Stimulating Factor; Hepatectomy; Hepatoblastoma; Humans; Ifosfamide; Immunoglobulin G; Incidental Findings; Liver Neoplasms; Male; Melphalan; Mesna; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neuroblastoma; Radiotherapy, Adjuvant; Tomography, X-Ray Computed; Vincristine | 2008 |
RYBP stabilizes p53 by modulating MDM2.
Topics: Animals; Cell Cycle; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; DNA Damage; Down-Regulation; Etoposide; Feedback, Physiological; Genes, Tumor Suppressor; Humans; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Lung Neoplasms; Neoplasm Proteins; Protein Binding; Protein Interaction Mapping; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-mdm2; Recombinant Fusion Proteins; Repressor Proteins; RNA Interference; Tumor Suppressor Protein p53; Two-Hybrid System Techniques; Ubiquitination | 2009 |
Association analysis between the Cdc6 G1321A polymorphism and the risk for non-Hodgkin lymphoma and hepatocellular carcinoma.
Topics: Adult; Aged; Apoptosis; Carcinoma, Hepatocellular; Case-Control Studies; Cell Cycle Proteins; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Humans; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nuclear Proteins; Nucleic Acid Conformation; Polymorphism, Single Nucleotide; RNA, Messenger | 2009 |
[Clinical analysis of 81 cases with primary small cell carcinoma of the esophagus].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Etoposide; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplastic Cells, Circulating; Proportional Hazards Models; Retrospective Studies; Survival Rate | 2008 |
Desmoplastic small round cell tumor in children: a new therapeutic approach.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Child; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 22; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Neoadjuvant Therapy; Oncogene Proteins, Fusion; Pelvic Neoplasms; Radiotherapy, Adjuvant; Sarcoma, Small Cell; Splenic Neoplasms; Translocation, Genetic; Transplantation, Autologous; Vincristine | 2009 |
The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
Topics: Base Sequence; Binding Sites; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; DNA Methylation; E2F1 Transcription Factor; Etoposide; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Kruppel-Like Transcription Factors; Liver Neoplasms; Lung Neoplasms; Molecular Sequence Data; Promoter Regions, Genetic; RNA, Messenger; Sequence Alignment; Transcription, Genetic; Up-Regulation | 2009 |
[Clinical observation on the treatment outcome of 14 children with hepatoblastoma in a single medical center].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Hepatoblastoma; Humans; Ifosfamide; Infant; Liver Neoplasms; Male | 2009 |
Tunicamycin induces resistance to camptothecin and etoposide in human hepatocellular carcinoma cells: role of cell-cycle arrest and GRP78.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Drug Resistance, Neoplasm; Endoplasmic Reticulum Chaperone BiP; Etoposide; G1 Phase; Heat-Shock Proteins; Humans; Liver Neoplasms; Tunicamycin | 2009 |
[Complete remission with FLEP chemotherapy for multiple liver metastasis from alpha-fetoprotein-producing gastric cancer--report of a case].
Topics: Adenocarcinoma; alpha-Fetoproteins; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Combinations; Etoposide; Fluorouracil; Gastrectomy; Humans; Immunohistochemistry; Leucovorin; Liver Neoplasms; Male; Middle Aged; Oxonic Acid; Remission Induction; Stomach Neoplasms; Tegafur | 2009 |
Association of p53 with Bid induces cell death in response to etoposide treatment in hepatocellular carcinoma.
Topics: Antineoplastic Agents, Phytogenic; BH3 Interacting Domain Death Agonist Protein; Carcinoma, Hepatocellular; Cell Death; Cell Line; Cell Line, Tumor; Cell Nucleus; Cell Survival; DNA Damage; Etoposide; Humans; Liver Neoplasms; Mitochondria; Protein Binding; Protein Transport; RNA, Small Interfering; Tumor Suppressor Protein p53 | 2009 |
Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Carcinoma, Neuroendocrine; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Retrospective Studies | 2010 |
Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney that responded to low-dose chemotherapy with ifosfamide, etoposide, and doxorubicin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Doxorubicin; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Liver Neoplasms; Male; Nephrectomy; Neuroectodermal Tumors, Primitive; Positron-Emission Tomography; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2010 |
Hepatosplenic alphabeta T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Transplantation; Carboplatin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Liver Neoplasms; Lymphoma, T-Cell; Male; Methylprednisolone; Positron-Emission Tomography; Prednisolone; Receptors, Antigen, T-Cell, alpha-beta; Splenic Neoplasms; T-Lymphocytes; Tomography, X-Ray Computed; Transplantation Conditioning; Vincristine | 2010 |
Potentiation of etoposide-induced apoptosis in HeLa cells by co-treatment with KG-135, a quality-controlled standardized ginsenoside formulation.
Topics: Androstadienes; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Synergism; Etoposide; Female; Ginsenosides; HeLa Cells; Humans; Korea; Liver Neoplasms; Medicine, East Asian Traditional; Membrane Potentials; Mitochondria; Mycotoxins; Phosphoserine; Stomach Neoplasms; Wortmannin | 2010 |
Salvage chemotherapy with methotrexate, etoposide and actinomycin D in men with metastatic nonseminomatous germ cell tumors with a choriocarcinoma component: a preliminary report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin; Choroid Neoplasms; Dactinomycin; Etoposide; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasms, Germ Cell and Embryonal; Salvage Therapy; Testicular Neoplasms; Treatment Outcome | 2010 |
Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hepatoblastoma; Humans; Ifosfamide; Infant; Infant, Newborn; Japan; Liver; Liver Neoplasms; Male; Survival Analysis; Treatment Outcome | 2011 |
Ki-67 index, tumor differentiation, and extent of liver involvement are independent prognostic factors in patients with liver metastases of digestive endocrine carcinomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Digestive System Neoplasms; Etoposide; Female; Humans; Kaplan-Meier Estimate; Ki-67 Antigen; Liver Neoplasms; Male; Middle Aged; Retrospective Studies | 2011 |
A mediastinal somatic-type germ cell tumor with hepatic metastasis successfully treated by multiple modalities.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Etoposide; Humans; Liver Neoplasms; Male; Mediastinal Neoplasms; Rhabdomyosarcoma, Embryonal; Teratoma | 2010 |
Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Floxuridine; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2011 |
Autophagy inhibition enhances etoposide-induced cell death in human hepatoma G2 cells.
Topics: Adenine; AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Carcinoma, Hepatocellular; DNA Damage; Etoposide; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Membrane Proteins; RNA, Small Interfering; Signal Transduction; Tumor Suppressor Protein p53 | 2011 |
Acetylcholinesterase, a key prognostic predictor for hepatocellular carcinoma, suppresses cell growth and induces chemosensitization.
Topics: Acetylcholinesterase; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Doxorubicin; Etoposide; Female; Humans; Liver Neoplasms; Male; Mice; Middle Aged; Mitogen-Activated Protein Kinase Kinases; Phosphatidylinositol 3-Kinases; Prognosis; Proto-Oncogene Proteins c-akt; Recombinant Proteins; Signal Transduction; Survival Rate; Transplantation, Heterologous | 2011 |
Trichostatin A sensitizes HBx-expressing liver cancer cells to etoposide treatment.
Topics: BH3 Interacting Domain Death Agonist Protein; Caspases; Cell Death; Cell Nucleus; Drug Screening Assays, Antitumor; Enzyme Activation; Etoposide; Extracellular Signal-Regulated MAP Kinases; Green Fluorescent Proteins; Hep G2 Cells; Humans; Hydroxamic Acids; Liver Neoplasms; Phosphorylation; Protein Transport; Trans-Activators; Tumor Suppressor Protein p53; Viral Regulatory and Accessory Proteins | 2011 |
The first case of primary testicular germ cell tumor containing nephroblastoma as the only one non-germ cell component.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Liver Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Taxoids; Testicular Neoplasms; Wilms Tumor; Young Adult | 2011 |
Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents.
Topics: Animals; Antineoplastic Agents; Benzenesulfonates; Camptothecin; Carcinoma, Hepatocellular; Cell Death; Cell Nucleus; Cytoplasm; Deoxycytidine; Doxorubicin; Drug Synergism; Etoposide; Female; Fluorouracil; Gemcitabine; Genes, p53; Humans; Irinotecan; Liver Neoplasms; Mice; Microtubule-Associated Proteins; Myeloid Cell Leukemia Sequence 1 Protein; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins c-bcl-2; Pyridines; Quinacrine; Receptors, TNF-Related Apoptosis-Inducing Ligand; RNA, Small Interfering; Sorafenib; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2011 |
[Poorly-differentiated neuroendocrine carcinoma of ascending colon with liver metastases successfully treated with carboplatin and etoposide].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cell Differentiation; Colonic Neoplasms; Combined Modality Therapy; Etoposide; Female; Humans; Liver Neoplasms | 2011 |
Etoposide, cisplatin-etoposide, methotrexate, actinomycin-D as primary treatment for management of very-high-risk gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dactinomycin; Disease Progression; Etoposide; Female; Gestational Trophoblastic Disease; Humans; India; Liver Neoplasms; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk; Salvage Therapy; Survival Rate; Treatment Outcome; Young Adult | 2011 |
Verticillin A overcomes apoptosis resistance in human colon carcinoma through DNA methylation-dependent upregulation of BNIP3.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cisplatin; Colonic Neoplasms; DNA Methylation; Drug Resistance, Neoplasm; Etoposide; Fas Ligand Protein; Female; Gene Expression Regulation, Neoplastic; Humans; Indoles; Liver Neoplasms; Membrane Proteins; Mice; Mice, Nude; Neoplasm Proteins; Promoter Regions, Genetic; Proto-Oncogene Proteins; Recombinant Proteins; RNA Interference; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand; Up-Regulation; Xenograft Model Antitumor Assays | 2011 |
An unusual cause for weight loss and diabetes.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Diabetes Mellitus; Etoposide; Glucagonoma; Humans; Liver Neoplasms; Male; Octreotide; Pancreatic Neoplasms; Weight Loss | 2011 |
Hypoxia-inducible factor-1α and excision repair cross-complementing 1 in patients with small cell lung cancer who received front-line platinum-based chemotherapy: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Brain Neoplasms; Camptothecin; Carboplatin; Cisplatin; DNA-Binding Proteins; Endonucleases; Etoposide; Female; Follow-Up Studies; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoenzyme Techniques; Irinotecan; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate | 2012 |
Metastatic extraosseous Ewing's sarcoma (EES)/primitive neuroectodermal tumor (PNET) of the kidney: 8-year durable response after induction and maintenance chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Humans; Ifosfamide; Induction Chemotherapy; Kidney Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Maintenance Chemotherapy; Male; Middle Aged; Neuroectodermal Tumors, Primitive; Radiography; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2012 |
Clinical characteristics of the patients with Hodgkin's lymphoma involving extranodal sites.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Remission Induction; Retrospective Studies; Survival Rate; Vinblastine; Vincristine; Young Adult | 2012 |
Etoposide induces a mixed type of programmed cell death and overcomes the resistance conferred by Bcl-2 in Hep3B hepatoma cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Beclin-1; Carcinoma, Hepatocellular; Caspase Inhibitors; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Humans; Liver Neoplasms; Membrane Proteins; Staurosporine | 2012 |
Regression of mesenchymal hamartoma of the liver with sarcoma chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Diagnostic Errors; Doxorubicin; Etoposide; Female; Hamartoma; Humans; Ifosfamide; Liver Neoplasms; Mesoderm; Prognosis; Sarcoma, Ewing; Vincristine; Young Adult | 2013 |
FOLFIRI regimen: an effective second-line chemotherapy after failure of etoposide-platinum combination in patients with neuroendocrine carcinomas grade 3.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Camptothecin; Carcinoma, Neuroendocrine; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoplasm Grading; Pancreatic Neoplasms; Pelvic Neoplasms; Platinum; Treatment Outcome | 2012 |
TMEM45A is essential for hypoxia-induced chemoresistance in breast and liver cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Cells, Cultured; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Kaplan-Meier Estimate; Keratinocytes; Liver Neoplasms; Membrane Proteins; Oligonucleotide Array Sequence Analysis; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Transcriptome | 2012 |
Pathological complete response and two-year disease-free survival in a primary gastric choriocarcinoma patient with advanced liver metastases treated with germ cell tumor-based chemotherapy: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Choriocarcinoma, Non-gestational; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Disease-Free Survival; Docetaxel; Etoposide; Fluorouracil; Humans; Liver Neoplasms; Male; Neoplasm, Residual; Stomach Neoplasms; Survival Analysis; Taxoids | 2012 |
Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carboplatin; Carcinoma, Neuroendocrine; Cystectomy; Etoposide; Female; Gallbladder Neoplasms; Hepatectomy; Humans; Immunohistochemistry; Liver Neoplasms; Lymph Node Excision; Middle Aged; Neoadjuvant Therapy; Neoplasms, Complex and Mixed; Octreotide; Paclitaxel; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidant Response Elements; Antioxidants; Apoptosis; bcl-X Protein; Carcinoma, Hepatocellular; Caspases; Cell Line, Tumor; Cell Survival; Cytoprotection; Drug Resistance, Neoplasm; Etoposide; HEK293 Cells; Hepatoblastoma; Humans; Hydroquinones; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Liver Neoplasms; Mice; NF-E2-Related Factor 2; Promoter Regions, Genetic; RNA Interference | 2013 |
Efficacy and toxicity of intra-arterial cisplatin and etoposide for advanced hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Etoposide; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Survival Rate | 2002 |
Sox-4 is a positive regulator of Hep3B and HepG2 cells' apoptosis induced by prostaglandin (PG)A(2) and delta(12)-PGJ(2).
Topics: Apoptosis; Blotting, Western; Calcimycin; Caspase 1; Caspase Inhibitors; Etoposide; Gene Expression Regulation, Neoplastic; High Mobility Group Proteins; Humans; Liver Neoplasms; Oligopeptides; Prostaglandin D2; Prostaglandins A; SOXC Transcription Factors; Trans-Activators; Transfection; Tumor Cells, Cultured | 2002 |
[Regulative function of extracelluar regulated protein kinases and telomerase in apoptosis of hepatocarcinomatous cell SMMC-7721].
Topics: Apoptosis; Carcinoma, Hepatocellular; Etoposide; Harringtonines; Humans; Liver Neoplasms; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Signal Transduction; Telomerase; Tumor Cells, Cultured; Vincristine | 2002 |
Different effects of p58PITSLRE on the apoptosis induced by etoposide, cycloheximide and serum-withdrawal in human hepatocarcinoma cells.
Topics: Apoptosis; Blood Volume; Cell Death; Culture Media, Serum-Free; Cyclin-Dependent Kinases; Cycloheximide; Etoposide; Female; Humans; In Situ Nick-End Labeling; Liver; Liver Neoplasms; Luminescent Measurements; Protein Kinases; Protein Serine-Threonine Kinases; Tumor Cells, Cultured | 2002 |
[Localization of primary small cell carcinoma with liver metastasis: a rare combination of colonic adenocarcinoma and undifferentiated small cell carcinoma].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Colectomy; Colon; Colonic Neoplasms; Docetaxel; Doxorubicin; Etoposide; Female; Humans; Immunohistochemistry; Liver; Liver Neoplasms; Neoplasms, Multiple Primary; Neoplasms, Unknown Primary; Paclitaxel; Taxoids; Time Factors; Vincristine | 2002 |
Squamous cell carcinoma of the colon with an elevated serum squamous cell carcinoma antigen responding to combination chemotherapy.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cisplatin; Colonic Neoplasms; Etoposide; Fatal Outcome; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Serpins; Tomography, X-Ray Computed | 2001 |
Effects of ER-37328 on primary tumor, liver metastasis, and life span in a murine colon 38 orthotopic transplantation model.
Topics: Animals; Carbazoles; Cell Division; Colonic Neoplasms; Etoposide; Female; Humans; Liver Neoplasms; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Neoplasm Metastasis; Pyrimidines; Survival Analysis; Time Factors; Transplantation, Heterologous | 2003 |
Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
Topics: Adult; Allopurinol; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Cisplatin; Etoposide; Fluid Therapy; Humans; Liver Neoplasms; Male; Medulloblastoma; Renal Dialysis; Tumor Lysis Syndrome | 2003 |
A case of aggressive neuroendocrine carcinoma of the stomach.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Fluorouracil; Gastrectomy; Humans; Liver Neoplasms; Male; Middle Aged; Omentum; Pancreatic Neoplasms; Peritoneal Neoplasms; Stomach Neoplasms; Tomography, X-Ray Computed | 2003 |
Metallothionein is a potential negative regulator of apoptosis.
Topics: Apoptosis; Cadmium; Carcinoma, Hepatocellular; Caspase 3; Caspases; Cell Line, Tumor; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Combinations; Etoposide; Hepatocytes; Humans; Liver Neoplasms; Lung Neoplasms; Metallothionein; Zinc | 2003 |
Small cell carcinoma of the esophagus with reference to alternating multiagent chemotherapy: report of two cases.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Liver Neoplasms; Male; Middle Aged; Peptide Fragments; Vincristine | 2003 |
Use of sarcoma-based chemotherapy in a case of congenital mesoblastic nephroma with liver metastases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Kidney Neoplasms; Liver Neoplasms; Nephroma, Mesoblastic; Sarcoma; Vincristine | 2003 |
Etoposide upregulates Bax-enhancing tumour necrosis factor-related apoptosis inducing ligand-mediated apoptosis in the human hepatocellular carcinoma cell line QGY-7703.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; BH3 Interacting Domain Death Agonist Protein; Carcinoma; Carrier Proteins; Caspases; Cell Survival; Cytochrome c Group; Etoposide; Humans; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Membrane Glycoproteins; Mitochondrial Proteins; Models, Biological; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53 | 2003 |
Combined therapy with a new bisphosphonate, minodronate (YM529), and chemotherapy for multiple organ metastases of small cell lung cancer cells in severe combined immunodeficient mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Carcinoma, Small Cell; Cell Division; Diphosphonates; Drug Combinations; Etoposide; Humans; Imidazoles; Kidney Neoplasms; Killer Cells, Natural; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Mice, Inbred ICR; Mice, SCID; Osteoclasts; Parathyroid Hormone-Related Protein; Survival Rate; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2003 |
[Focal concentrations in the hepatic CT in superior vena cava thrombosis].
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Liver; Liver Neoplasms; Lymphoma, B-Cell; Prednisolone; Rituximab; Superior Vena Cava Syndrome; Time Factors; Tomography, X-Ray Computed; Vincristine | 2003 |
Rectal adenocarcinoma with germ-cell differentiation: report of a case.
Topics: Adenocarcinoma; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Transformation, Neoplastic; Cisplatin; Combined Modality Therapy; Etoposide; Fluorouracil; Germinoma; Humans; Liver Neoplasms; Male; Palliative Care; Rectal Neoplasms | 2003 |
[A case of isolated hepatic malignant lymphoma representing characteristic findings on radiological imaging].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Irinotecan; L-Lactate Dehydrogenase; Liver Neoplasms; Lymphoma; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Prednisolone; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2003 |
[A long-term survival case of hepatic metastasis of rectal carcinoid in which etoposide was effective].
Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoid Tumor; Combined Modality Therapy; Etoposide; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Rectal Neoplasms; Survivors | 2004 |
[A difficult case of advanced testicular choriocarcinoma effectively treated by chemotherapy and resection of lung metastasis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Choriocarcinoma; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Peripheral Blood Stem Cell Transplantation; Pneumonectomy; Testicular Neoplasms | 2004 |
Autocrine inhibition of chemotherapy response in human liver tumor cells by insulin-like growth factor-II.
Topics: Antineoplastic Agents; Apoptosis; Autocrine Communication; Carcinoma, Hepatocellular; Cell Division; Cisplatin; Etoposide; Humans; In Situ Nick-End Labeling; Insulin-Like Growth Factor II; Liver Neoplasms; Tumor Cells, Cultured | 2004 |
Adeno-associated virus mediated endostatin gene therapy in combination with topoisomerase inhibitor effectively controls liver tumor in mouse model.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Hepatocellular; Cell Line, Tumor; Combined Modality Therapy; Drug Synergism; Endostatins; Endothelium, Vascular; Enzyme Inhibitors; Etoposide; Gene Expression; Genetic Therapy; Humans; Liver Neoplasms; Mice; Sarcoma; Survival Rate; Topoisomerase Inhibitors; Umbilical Veins | 2004 |
Metastatic Merkel cell tumor to the prostate and bladder.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Combined Modality Therapy; Etoposide; Facial Neoplasms; Fatal Outcome; Humans; Kidney Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Male; Palliative Care; Prostatic Neoplasms; Radiotherapy, Adjuvant; Spinal Neoplasms; Transurethral Resection of Prostate; Urethral Obstruction; Urinary Bladder Neoplasms | 2004 |
[Tumor lysis syndrome after chemotherapy for colon small cell carcinoma].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Etoposide; Female; Hearing Loss; Humans; Liver Neoplasms; Middle Aged; Postoperative Care; Tumor Lysis Syndrome | 2004 |
Primary germ cell tumor of the diaphragm.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Diagnosis, Differential; Diaphragm; Endodermal Sinus Tumor; Etoposide; Follow-Up Studies; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Muscle Neoplasms; Remission Induction | 2004 |
[Successful treatment with etoposide by oral administration for recurrence of gastric diffuse large B-cell lymphoma after surgical resection--a case report].
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Etoposide; Female; Gastrectomy; Humans; Ileal Neoplasms; Liver Neoplasms; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Remission Induction; Stomach Neoplasms | 2005 |
Role of interleukin-18 and its receptor in hepatocellular carcinoma associated with hepatitis C virus infection.
Topics: Aged; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Carcinoma, Hepatocellular; Cytokines; Electrophoretic Mobility Shift Assay; Etoposide; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interleukin-18; Interleukin-18 Receptor alpha Subunit; Liver Neoplasms; Male; Middle Aged; NF-kappa B; Receptors, Interleukin; Receptors, Interleukin-18; Recombinant Proteins; RNA, Messenger; Survival Rate; X-Linked Inhibitor of Apoptosis Protein | 2006 |
The role of T-fimbrin in the response to DNA damage: silencing of T-fimbrin by small interfering RNA sensitizes human liver cancer cells to DNA-damaging agents.
Topics: Actins; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Azacitidine; Carcinogens; Cell Cycle; Cell Line, Tumor; Cell Separation; Cytoskeleton; Decitabine; DNA Damage; DNA Methylation; Etoposide; Flow Cytometry; G2 Phase; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Immunoblotting; Liver Neoplasms; Membrane Glycoproteins; Microfilament Proteins; Microscopy, Fluorescence; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Time Factors; Transfection; Ultraviolet Rays | 2005 |
Transfection of Smac sensitizes tumor cells to etoposide-induced apoptosis and eradicates established human hepatoma in vivo.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Bone Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Combined Modality Therapy; Etoposide; Female; Fluorouracil; Genetic Therapy; Humans; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondrial Proteins; Osteosarcoma; Proto-Oncogene Proteins c-bcl-2; Transfection; Tumor Suppressor Protein p53 | 2006 |
[The hepatic artery injection chemotherapy and prostaglandin E1 administration for hepatocellular carcinoma invading the biliary tract with jaundice].
Topics: Aged; Alprostadil; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Cyclophosphamide; Doxorubicin; Etoposide; Fluorouracil; Humans; Injections, Intra-Arterial; Jaundice; Liver Neoplasms; Male | 2005 |
3,3'-diindolylmethane is a novel topoisomerase IIalpha catalytic inhibitor that induces S-phase retardation and mitotic delay in human hepatoma HepG2 cells.
Topics: Antigens, Neoplasm; Carcinoma, Hepatocellular; Cell Line, Tumor; Comet Assay; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Etoposide; Humans; Indoles; Liver Neoplasms; Microscopy, Confocal; Mitosis; S Phase; Topoisomerase II Inhibitors | 2006 |
Massive hemoptysis as a rare presentation of metastatic choriocarcinoma.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchoalveolar Lavage Fluid; Bronchoscopy; Choriocarcinoma; Chorionic Gonadotropin; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Hemoptysis; Humans; Liver Neoplasms; Lung Neoplasms; Radiography, Thoracic; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Uterine Neoplasms | 2006 |
Metastatic choriocarcinoma successfully treated with paclitaxel and carboplatin after interstitial lung disease induced by EMA-CO.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Liver Neoplasms; Lung Diseases, Interstitial; Lung Neoplasms; Methotrexate; Paclitaxel; Uterine Neoplasms; Vincristine | 2006 |
Intravascular hemolysis as a complication of clostridium perfringens sepsis.
Topics: Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Carcinoma, Small Cell; Cisplatin; Clostridium Infections; Clostridium perfringens; Etoposide; Hemolysis; Humans; Jaundice, Obstructive; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Systemic Inflammatory Response Syndrome | 2006 |
Treatment and prognosis of post term choriocarcinoma in The Netherlands.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Liver Neoplasms; Lung Neoplasms; Methotrexate; Netherlands; Pregnancy; Prognosis; Retrospective Studies; Uterine Neoplasms; Vincristine | 2006 |
Hypoxia protects HepG2 cells against etoposide-induced apoptosis via a HIF-1-independent pathway.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Caspases; Cell Hypoxia; Cobalt; DNA Fragmentation; Etoposide; Fluorescent Antibody Technique; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; RNA, Small Interfering; Signal Transduction; Transcription Factor AP-1; Transfection; Tumor Cells, Cultured | 2006 |
A case of metastatic testicular cancer complicated by tumour lysis syndrome and choriocarcinoma syndrome.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Drug Administration Schedule; Etoposide; Hemorrhage; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Radiography, Abdominal; Seminoma; Taxoids; Testicular Neoplasms; Tomography, X-Ray Computed; Tumor Lysis Syndrome | 2006 |
[A non-seminomatous extra-gonadal germ cell tumor responding to intensive treatment: a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Paclitaxel; Retroperitoneal Neoplasms | 2006 |
Stage 4S neuroblastoma, a disseminated tumor with excellent outcome.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Age Factors; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hepatomegaly; Humans; Infant; Infant, Newborn; Liver Neoplasms; Male; Neoplasm Regression, Spontaneous; Neoplasm Staging; Neuroblastoma; Prognosis; Retrospective Studies; Saudi Arabia; Skin; Skin Neoplasms; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2006 |
Statins induce mammalian target of rapamycin (mTOR)-mediated inhibition of Akt signaling and sensitize p53-deficient cells to cytostatic drugs.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Atorvastatin; Carcinoma, Hepatocellular; Cell Proliferation; Chromones; Dose-Response Relationship, Drug; Etoposide; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Neoplasms; Morpholines; Phosphorylation; Pravastatin; Protein Kinases; Proto-Oncogene Proteins c-akt; Pyrroles; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53 | 2006 |
Evidence of a novel antiapoptotic factor: role of inhibitor of differentiation or DNA binding (Id-1) in anticancer drug-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Cell Survival; Cisplatin; Down-Regulation; Doxorubicin; Etoposide; Female; HeLa Cells; Humans; Inhibitor of Differentiation Protein 1; Liver Neoplasms; Male; Mechlorethamine; Methotrexate; Mitomycin; Nasopharyngeal Neoplasms; Paclitaxel; Prostatic Neoplasms; Vincristine | 2007 |
Ectopic Cushing's syndrome due to concurrent corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) secreted by malignant gastrinoma.
Topics: Adrenocorticotropic Hormone; Adult; Antineoplastic Combined Chemotherapy Protocols; Corticotropin-Releasing Hormone; Cushing Syndrome; Duodenal Neoplasms; Etoposide; Female; Gastrinoma; Humans; Hydrocortisone; Liver Neoplasms; Paclitaxel; Pancreatic Neoplasms | 2007 |
Curative surgery after neoadjuvant chemotherapy in metastatic poorly differentiated neuroendocrine carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Pancreas; Remission Induction; Tomography, X-Ray Computed | 2007 |
[Multiple hepatic metastases due to germ cell tumor on initial clinical presentation].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma, Non-gestational; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Drug Administration Routes; Etoposide; Humans; Liver Neoplasms; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal | 2007 |
Synergic CSE1L/CAS, TNFR-1, and p53 apoptotic pathways in combined interferon-gamma/adriamycin-induced apoptosis of Hep G2 hepatoma cells.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; bcl-Associated Death Protein; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cellular Apoptosis Susceptibility Protein; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Humans; Interferon Regulatory Factor-1; Interferon-gamma; Liver Neoplasms; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction; Transfection; Tumor Suppressor Protein p53 | 2007 |
Persistent positron emission tomography-positive liver lesions after successful chemotherapy in mediastinal seminoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Liver Diseases; Liver Neoplasms; Male; Mediastinal Neoplasms; Neoplasm, Residual; Positron-Emission Tomography; Seminoma | 2007 |
Bcl-2 gene silencing in pediatric epithelial liver tumors.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Child; Cisplatin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epithelium; Etoposide; Gene Silencing; Genetic Therapy; Humans; Liver Neoplasms; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Transfection | 2008 |
A child with primary germ cell tumor of the liver.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Cisplatin; Etoposide; Humans; Liver Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Vinblastine | 2007 |
Seleno-podophyllotoxin derivatives induce hepatoma SMMC-7721 cell apoptosis through Bax pathway.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Shape; Cytochromes c; Etoposide; Humans; Liver Neoplasms; Membrane Potentials; Mitochondria; Molecular Structure; Podophyllotoxin | 2008 |
Efficacy and safety of epirubicin and etoposide combination chemotherapy in advanced hepatocellular carcinoma: a retrospective analysis.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Epirubicin; Etoposide; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Retrospective Studies | 2008 |
Successful multimodal treatment in a patient with thymoma accompanied by hepatic metastasis.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biopsy, Needle; Catheter Ablation; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Liver Neoplasms; Middle Aged; Myasthenia Gravis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Thymectomy; Thymoma; Thymus Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Cytotoxic effects and in vitro reversal of multidrug resistance by therapeutic ultrasound in human hepatocarcinoma cell line (HepG2).
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cisplatin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Fluorouracil; Humans; In Vitro Techniques; Liver Neoplasms; Rhodamines; Ultrasonic Therapy; Vincristine | 2008 |
[Primary neuroendocrine carcinoma of the liver. From carcinoid tumor to small-cell hepatic carcinoma: case reports and review of the literature].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoid Tumor; Carcinoma; Carcinoma, Neuroendocrine; Cell Differentiation; Etoposide; Female; Follow-Up Studies; Humans; Liver Neoplasms; Rectal Neoplasms; Risk Factors; Treatment Outcome | 2008 |
Bid exhibits S phase checkpoint activation and plays a pro-apoptotic role in response to etoposide-induced DNA damage in hepatocellular carcinoma cells.
Topics: Apoptosis; BH3 Interacting Domain Death Agonist Protein; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA Damage; Down-Regulation; Etoposide; Humans; Liver Neoplasms; S Phase; Tumor Suppressor Protein p53 | 2008 |
Primary hepatic Burkitt lymphoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cytarabine; Etoposide; Humans; Ifosfamide; Liver Neoplasms; Magnetic Resonance Imaging; Male | 2008 |
Primary small cell carcinoma of the breast.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Carboplatin; Carcinoma, Small Cell; Etoposide; Fatal Outcome; Female; Humans; Irinotecan; Liver Neoplasms; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Thoracic Wall | 2009 |
Diamminodichloride platinum (cis-platinum) in the treatment of hepatocellular carcinoma.
Topics: Adolescent; Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Kidney Function Tests; Liver Neoplasms; Male; Middle Aged; Nausea; Time Factors; Vomiting | 1981 |
Phase II study of oral VP-16-213 in hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Drug Evaluation; Etoposide; Humans; Liver Neoplasms; Middle Aged; Podophyllotoxin | 1981 |
Etoposide single-agent chemotherapy for solid tumors.
Topics: Carcinoma, Hepatocellular; Etoposide; Female; Head and Neck Neoplasms; Humans; Liver Neoplasms; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Sarcoma; Soft Tissue Neoplasms | 1982 |
VP-16-213 and cisplatin in the treatment of patients with refractory germ cell tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Etoposide; Female; Fever; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms, Germ Cell and Embryonal | 1984 |
Long-term survival associated with metastatic small cell carcinoma of the esophagus treated by chemotherapy, autologous bone marrow transplantation, and adjuvant radiation therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Esophageal Neoplasms; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Liver Neoplasms; Lymphatic Metastasis; Melphalan; Prognosis; Radiotherapy Dosage; Transplantation, Autologous; Vincristine | 1994 |
Clostridium septicum abscess in hepatic metastases: successful medical management.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carmustine; Ceftazidime; Cisplatin; Clindamycin; Clostridium Infections; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Gases; Granulocyte Colony-Stimulating Factor; Humans; Imipenem; Immunocompromised Host; Liver Abscess; Liver Neoplasms; Methotrexate; Neutropenia; Sepsis | 1994 |
[A case of AFP (alpha-fetoprotein) producing gastric cancer successfully treated with EAP (etoposide, adriamycin, cisplatin) therapy].
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Liver Neoplasms; Male; Middle Aged; Stomach Neoplasms | 1994 |
Recurrent ovarian sex cord tumor with annular tubules: tumor marker and chemotherapy experience.
Topics: Adult; Anti-Mullerian Hormone; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carcinoembryonic Antigen; Cisplatin; Etoposide; Female; Glycoproteins; Growth Inhibitors; Humans; Inhibins; Liver Neoplasms; Ovarian Neoplasms; Sex Cord-Gonadal Stromal Tumors; Testicular Hormones | 1994 |
[Evaluation of 5-FU, leucovorin, etoposide, and cisplatin (FLEP) chemotherapy by hepatic artery injection in the treatment of multiple liver metastases from gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Stomach Neoplasms | 1995 |
Successful liver treatment of a juvenile granulosa cell tumor in a 4-year-old child by regional deep hyperthermia, systemic chemotherapy, and irradiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child, Preschool; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Granulosa Cell Tumor; Humans; Hyperthermia, Induced; Ifosfamide; Liver Neoplasms; Ovarian Neoplasms; Ovariectomy; Ovary; Remission Induction; Temperature; Transaminases | 1995 |
High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Hemorrhage; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Neutropenia; Remission Induction; Survival Rate; Thrombocytopenia | 1994 |
Combination therapy consisting of arterial infusion chemotherapy (EPF, EAP) and transcatheter arterial embolization (TAE).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Survival Rate; Tomography, X-Ray Computed | 1994 |
[Effects of cisplatin, carboplatin, etoposide and human hepatocyte growth factor on the colony formation of four human liver cancer cell lines].
Topics: Carboplatin; Carcinoma, Hepatocellular; Cisplatin; Drug Synergism; Etoposide; Hepatoblastoma; Hepatocyte Growth Factor; Humans; Liver Neoplasms; Neoplastic Stem Cells; Recombinant Proteins; Tumor Cells, Cultured | 1993 |
[Successful treatment of two patients with advanced gastric cancer by neoadjuvant chemotherapy with EAP regimen].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Hepatic Artery; Humans; Infusion Pumps, Implantable; Liver Neoplasms; Male; Middle Aged; Stomach Neoplasms | 1994 |
[Intraarterial infusion chemotherapy for recurrent or unresectable gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Mitomycin; Peritonitis; Prognosis; Stomach Neoplasms; Survival Rate | 1993 |
[The effect and pharmacokinetics of etoposide in patients with primary hepatocellular carcinoma].
Topics: Administration, Oral; Carcinoma, Hepatocellular; Drug Administration Schedule; Etoposide; Female; Humans; Liver Neoplasms; Male; Middle Aged | 1993 |
Liver metastases of gestational trophoblastic tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Liver Neoplasms; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms | 1993 |
Cisplatin-resistant metastatic hepatoblastoma: complete response to carboplatin, etoposide, and liver transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Cisplatin; Combined Modality Therapy; Drug Resistance; Etoposide; Female; Humans; Infant; Liver Neoplasms; Liver Transplantation; Lung Neoplasms; Remission Induction | 1993 |
Combination chemotherapy for a senile patient with adenoid cystic carcinoma of the esophagus: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Esophageal Neoplasms; Esophagoscopy; Esophagus; Etoposide; Female; Humans; Liver Neoplasms; Tegafur; Tomography, X-Ray Computed | 1993 |
[Evaluation of the combination of chemotherapy with etoposide, adriamycin and cisplatin (EAP) in advanced or recurrent gastric cancer].
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Liver Neoplasms; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Stomach Neoplasms; Survival Rate; Vomiting | 1993 |
[A case of gastric cancer with multiple liver metastases showing marked efficacy of preoperative and postoperative chemotherapy with CDDP, MMC and UFT(PMU), or CDDP, MMC, UFT and etoposide (PMUE)].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Hepatectomy; Hepatic Artery; Humans; Infusion Pumps; Liver Neoplasms; Lymphatic Metastasis; Male; Mitomycin; Postoperative Care; Preoperative Care; Stomach Neoplasms; Tegafur; Uracil | 1993 |
Solitary plasmacytoma of bone--a rare disorder with an unusual evolution.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Liver Neoplasms; Multiple Myeloma; Plasmacytoma; Spinal Neoplasms; Splenectomy; Splenic Neoplasms; Vincristine | 1993 |
Extensive stage small cell lung cancer: determining suitability for outpatient management of febrile neutropenia.
Topics: Adrenal Gland Neoplasms; Ambulatory Care; Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Decision Making; Etoposide; Female; Fever; Hospitalization; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neutropenia | 1996 |
Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases.
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Frontal Lobe; Humans; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Paclitaxel; Platinum; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Neoplasms; Vincristine | 1996 |
Treatment of metastatic adrenal cortical carcinoma with etoposide (VP-16) and cisplatin after failure with o,p'DDD. Clinical case reports.
Topics: Adrenal Cortex Neoplasms; Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Etoposide; Female; Humans; Liver Neoplasms; Mitotane | 1996 |
Antimetastatic effect of a novel indolocarbazole (NB-506) on IMC-HM murine tumor cells metastasized to the liver.
Topics: Animals; Antineoplastic Agents; Carbazoles; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Female; Glucosides; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred DBA | 1996 |
Unchanged pharmacokinetics of etoposide given by intra-arterial hepatic infusion as compared with i.v. infusion.
Topics: Adult; Etoposide; Half-Life; Hepatic Artery; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Liver; Liver Neoplasms; Male; Metabolic Clearance Rate; Tissue Distribution | 1996 |
[A case of early gastric cancer transformed from adenoma by chemotherapy and radiotherapy].
Topics: Adenoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Liver Neoplasms; Lymphoma; Male; Neoplasms, Second Primary; Prednisolone; Stomach Neoplasms; Tegafur; Uracil; Vincristine | 1996 |
[Combined chemotherapy with MMC, ADM, CDDP, etoposide (VP-16) and 5'-DFUR, (MACVD therapy) as a second-line chemotherapy for metastatic gastric cancer: three cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Floxuridine; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Stomach Neoplasms | 1996 |
[Therapy-related AML(M2) with t(8;21) that developed three years after chemotherapy for hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Doxorubicin; Epirubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Liver Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Translocation, Genetic | 1996 |
[Chemohyperthermic peritoneal perfusion and high-dose chemotherapy followed by peripheral blood stem cell transplantation in advanced colon cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Colonic Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Hyperthermia, Induced; Liver Neoplasms; Lung Neoplasms; Middle Aged; Mitomycin; Perfusion; Peritoneum | 1996 |
[A patient with HCC successfully treated by ethanol injection therapy with etoposide].
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Ethanol; Etoposide; Humans; Injections, Intralesional; Liver Neoplasms; Male | 1996 |
Unusual presentation of a metastatic choriocarcinoma following a full term pregnancy: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dactinomycin; Etoposide; Fatal Outcome; Female; Humans; Liver Neoplasms; Methotrexate; Pregnancy; Uterine Neoplasms; Vincristine | 1996 |
[A case of advanced gastric cancer with multiple liver metastasis successfully treated with combination chemotherapy using UFT, CDDP and etoposide].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Combinations; Etoposide; Humans; Injections, Intravenous; Lentinan; Leukopenia; Liver Neoplasms; Male; Nausea; Stomach Neoplasms; Tegafur; Thrombocytopenia; Uracil | 1996 |
[A case of advanced gastric cancer showing complete disappearance of cancer cells in multiple liver metastases due to low-dose PMUE therapy].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mitomycin; Stomach Neoplasms; Tegafur; Uracil | 1996 |
Determination of unbound etoposide concentration in ultrafiltered plasma by high-performance liquid chromatography with fluorimetric detection.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Calibration; Carcinoma, Hepatocellular; Chromatography, High Pressure Liquid; Etoposide; Fluorometry; Hemofiltration; Humans; Linear Models; Liver Neoplasms; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 1996 |
Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32.
Topics: Apoptosis; Camptothecin; Carcinoma, Hepatocellular; Caspase 1; Caspase 3; Caspases; Cell Line; Cysteine Endopeptidases; Endopeptidases; Enzyme Inhibitors; Etoposide; Humans; Kinetics; Liver Neoplasms; Protease Inhibitors; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1996 |
Hepatic angiosarcoma in a child: successful therapy with surgery and adjuvant chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hemangiosarcoma; Humans; Ifosfamide; Liver Neoplasms; Vincristine | 1997 |
[Chemosensitivity test on hepatocellular carcinoma (HCC) and drug resistance].
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cisplatin; Cytochrome P-450 Enzyme System; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Fluorouracil; Glutathione Transferase; Humans; Liver Neoplasms; Metallothionein; Mitomycins; Tumor Cells, Cultured | 1996 |
Retinal toxicity associated with cisplatin and etoposide in pediatric patients.
Topics: Antineoplastic Agents; Bleomycin; Child; Child, Preschool; Cisplatin; Depth Perception; Etoposide; Evoked Potentials, Visual; Fatal Outcome; Female; Germinoma; Hepatoblastoma; Humans; Liver Neoplasms; Retina; Retroperitoneal Neoplasms; Visual Acuity | 1997 |
Cisplatin-based chemotherapy in advanced seminoma: experience of the Northern Israel Oncology Center: 1981-1994.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Remission Induction; Seminoma; Testicular Neoplasms; Vinblastine | 1997 |
Expression of P-glycoprotein and p53 in advanced hepatocellular carcinoma treated by single agent chemotherapy: clinical correlation.
Topics: Adult; Aged; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Doxorubicin; Etoposide; Female; Humans; Immunohistochemistry; Liver Neoplasms; Male; Middle Aged; Tumor Suppressor Protein p53 | 1997 |
Undifferentiated carcinoma of the liver with neuroendocrine features: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma; Cisplatin; Etoposide; Humans; Immunohistochemistry; Liver Neoplasms; Male; Middle Aged; Phosphopyruvate Hydratase; Synaptophysin | 1998 |
Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma.
Topics: alpha-Fetoproteins; Animals; Antineoplastic Agents; Carboplatin; Cell Division; Child, Preschool; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Hepatoblastoma; Humans; Ifosfamide; Infant; Liver Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous | 1998 |
[A case of small cell carcinoma of the stomach with multiple liver and lung metastases successfully treated by combined chemotherapy with cisplatin and etoposide].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Etoposide; Gastrectomy; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Splenectomy; Stomach Neoplasms | 1999 |
Hepatic artery administration of paclitaxel.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cimetidine; Combined Modality Therapy; Dexamethasone; Diphenhydramine; Etoposide; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Premedication | 1999 |
Pharmacokinetics of oral etoposide in patients with hepatocellular carcinoma.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Aspartate Aminotransferases; Bilirubin; Biological Availability; Blood Proteins; Carcinoma, Hepatocellular; Chromatography, High Pressure Liquid; Etoposide; Humans; Lidocaine; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Metabolic Clearance Rate; Middle Aged; Protein Binding; Serum Albumin; Ultrafiltration | 1999 |
[Successful combination chemotherapy for a case of small cell carcinoma of the rectum with multiple liver metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemoembolization, Therapeutic; Cisplatin; Doxorubicin; Etoposide; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Rectal Neoplasms | 1999 |
Candida famata fungemia in a cancer patient: case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Candida; Candidiasis; Cisplatin; Etoposide; Fatal Outcome; Female; Fungemia; Humans; Liver Neoplasms | 2000 |
Depletion of cellular glutathione by conditions used for the passaging of adherent cultured cells.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Communication; Cell Culture Techniques; Cell Death; Etoposide; Female; Glutathione; Humans; Hydrogen Peroxide; Liver Neoplasms; Oxidants; Rats; Toxicity Tests; Tumor Cells, Cultured | 2000 |
Transduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated virus (rAAV): in vitro and in vivo effects of genotoxic agents.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Line; Dependovirus; Etoposide; Gamma Rays; Gene Transfer Techniques; Genetic Vectors; Humans; Liver; Liver Neoplasms; Mice; Mice, Nude; Mutagens; Neoplasm Transplantation; Rats; Rats, Inbred BUF; Recombination, Genetic; Transduction, Genetic; Tumor Cells, Cultured | 2000 |
High-dose indium 111In pentetreotide radiotherapy for metastatic atypical carcinoid tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoid Tumor; Cisplatin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Liver Neoplasms; Lymphatic Metastasis; Radionuclide Imaging; Receptors, Somatostatin; Somatostatin | 2000 |
Acute tumor lysis syndrome with choriocarcinoma.
Topics: Acidosis; Acute Disease; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Etoposide; Fatal Outcome; Heart Arrest; Humans; Hyperkalemia; Hypocalcemia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Phosphates; Respiratory Insufficiency; Testicular Neoplasms; Tumor Lysis Syndrome; Uric Acid | 2000 |
[Hepatic arterial infusion chemotherapy using totally implantable port system].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin | 2000 |
Relationship between actin microfilaments and plasma membrane changes during apoptosis of neoplastic cell lines in different culture conditions.
Topics: Actin Cytoskeleton; Actins; Cell Culture Techniques; Cell Membrane; Etoposide; HL-60 Cells; Humans; Liver Neoplasms; Microscopy, Confocal; Microscopy, Electron, Scanning; Mitochondria; Tumor Cells, Cultured | 2000 |
[Three cases of liver metastasis of colon cancer responding to systemic combination chemotherapy utilizing CPT-11].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Irinotecan; Liver Neoplasms; Male; Tegafur; Uracil | 2000 |
Shunt-related abdominal metastases in an infant with medulloblastoma: long-term remission by systemic chemotherapy and surgery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cerebellar Neoplasms; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Hydrocephalus; Hydroxyurea; Infant; Liver Neoplasms; Magnetic Resonance Imaging; Male; Medulloblastoma; Neoplasm Recurrence, Local; Pelvic Neoplasms; Peritoneal Neoplasms; Remission Induction; Ventriculoperitoneal Shunt | 2001 |
Resistance to multiple agent chemotherapy including cisplatin after chronic low-dose oral etoposide administration in gestational choriocarcinoma.
Topics: Administration, Oral; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Hysterectomy; Liver; Liver Neoplasms; Pregnancy; Rectum; Uterine Neoplasms | 2001 |
Testicular germ cell tumor with rhabdomyosarcoma successfully treated by disease-adapted chemotherapy including high-dose chemotherapy: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Cell Differentiation; Cisplatin; Combined Modality Therapy; Diphosphonates; Epirubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Liver Neoplasms; Lumbar Vertebrae; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Multiple Primary; Orchiectomy; Pamidronate; Remission Induction; Rhabdomyosarcoma; Seizures; Seminoma; Spinal Neoplasms; Teratoma; Testicular Neoplasms; Transplantation, Autologous | 2001 |
Misleading leads: don't assume an alpha-fetoprotein secreting tumour is of germ cell or hepatic origin.
Topics: Abdomen; Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Diagnosis, Differential; Etoposide; Humans; Immunohistochemistry; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Pancreatic Neoplasms; Pancreaticoduodenectomy; Status Epilepticus | 2002 |
Cure in a case of primary hepatic lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Liver Neoplasms; Lymphoma; Male; Methotrexate; Prednisolone; Tomography, X-Ray Computed; Vincristine | 2000 |
The chemotherapy of metastatic gastric adenocarcinomas with hypersecretion of alpha-fetoprotein or beta-human chorionic gonadotrophin: report of two cases.
Topics: Adenocarcinoma; Adult; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin, beta Subunit, Human; Drug Resistance, Neoplasm; Etoposide; Humans; Liver Neoplasms; Male; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Survival Analysis | 2002 |
Epipodophyllin derivative (VP 16-213) in treatment of solid tumours.
Topics: Carcinoma, Hepatocellular; Etoposide; Humans; Liver Neoplasms; Podophyllotoxin; Teratoma | 1977 |
[Therapeutic results using VP 16-213 alone or in combination with 5-fluorouracil in liver cancer (hepatoma)].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Podophyllotoxin | 1977 |
[T-cell rich B-cell lymphoma associated with hemophagocytic syndrome].
Topics: Adult; Agranulocytosis; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Autopsy; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Histiocytosis, Non-Langerhans-Cell; HLA-DR Antigens; Humans; Liver Neoplasms; Lymph Nodes; Lymphoma, T-Cell; Macrophages; Male; Prednisone; Splenic Neoplasms; Vincristine | 1992 |
[A case with hepatocellular carcinoma effectively treated by continuous hepatic arterial infusion of etoposide, epirubicin and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Epirubicin; Etoposide; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged | 1992 |
Cisplatin therapy in infants: short and long-term morbidity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chlorambucil; Cisplatin; Electrolytes; Etoposide; Female; Glomerular Filtration Rate; Humans; Infant; Infant, Newborn; Liver Neoplasms; Male; Morbidity; Neuroblastoma; Prednisolone; Seizures; Teratoma; Time Factors; Vincristine | 1992 |
Arterial infusion chemotherapy for advanced hepatocellular carcinoma using EPF and EAP therapies.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged | 1992 |
Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy.
Topics: alpha-Fetoproteins; Analysis of Variance; Antineoplastic Agents; Ascites; Bilirubin; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Interferon-gamma; Liver Neoplasms; Male; Middle Aged; Mitoxantrone; Multivariate Analysis; Prognosis; Regression Analysis; Risk Factors; Serum Albumin; Tegafur; Time Factors | 1992 |
Successful treatment of a primary endodermal sinus tumor of the liver.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Hepatectomy; Humans; Liver Neoplasms; Mesonephroma; Methotrexate; Vincristine | 1992 |
[PMUE therapy (CDDP, MMC, UFT, etoposide) for advanced gastric cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Remission Induction; Reoperation; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[A case of gastric cancer with multiple liver metastases effectively treated with PMUE (CDDP, MMC, UFT, etoposide) hepatic arterial chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Gastrectomy; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Stomach Neoplasms; Tegafur; Uracil | 1992 |
Primary liver cancer in Hong Kong.
Topics: Adult; Aged; Epirubicin; Etoposide; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged | 1992 |
[A resected case of advanced gastric cancer with complete remission of liver metastasis by chronic daily administration of oral etoposide and UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Male; Mitomycin; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[Intra-arterial infusion chemotherapy for unresectable hepatocellular carcinoma using an implantable reservoir].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Mitomycin; Mitomycins | 1991 |
Cytoreductive surgery in disseminated non-seminomatous germ cell tumours of testis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Teratoma; Testicular Neoplasms; Vincristine | 1991 |
An application of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in a case of hepatocellular carcinoma combined with liver cirrhosis in which leukopenia developed after chemoembolization.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Neutropenia; Recombinant Proteins | 1991 |
Chemoimmunotherapy in conjunction with surgery: strategies for management of murine neuroblastoma.
Topics: Animals; Chemotherapy, Adjuvant; Combined Modality Therapy; Etoposide; Female; Liver Neoplasms; Mice; Mice, Inbred Strains; Neoplasm Recurrence, Local; Neuroblastoma; Recombinant Proteins; Tumor Necrosis Factor-alpha | 1991 |
[5'-deoxy-5-fluorouridine (5'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Etoposide; Female; Floxuridine; Humans; Liver Neoplasms; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Mitomycin; Mitomycins; Remission Induction | 1991 |
[CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Gastrectomy; Humans; Infusions, Parenteral; Injections, Intravenous; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Peritonitis; Stomach Neoplasms; Tegafur; Uracil | 1991 |
[Chemoembolization therapy with lipiodol, cisplatin and etoposide for hepatocellular carcinoma].
Topics: Aged; Carcinoma, Hepatocellular; Catheterization; Cisplatin; Embolization, Therapeutic; Etoposide; Female; Gelatin Sponge, Absorbable; Hepatic Artery; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged | 1990 |
[Treatment of liver metastatic ovarian cancer with sequential administration of OK-432 and etoposide].
Topics: Adult; Carcinoma, Hepatocellular; Etoposide; Female; Humans; Injections, Intravenous; Liver Neoplasms; Ovarian Neoplasms; Picibanil | 1990 |
Arterial chemoembolization for multiple liver metastases of uterine cancer. Two case reports.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Embolization, Therapeutic; Etoposide; Female; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Middle Aged; Uterine Neoplasms | 1990 |
[Hepatocellular carcinoma treated by continuous hepatic arterial infusion of etoposide, CDDP and 5-FU].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged | 1990 |
[Hepatic arterial infusion of etoposide in the treatment of primary liver neoplasms].
Topics: Adenoma, Bile Duct; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Etoposide; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged | 1990 |
[Intra-hepato-arterial infusion chemotherapy using catheter inserted and placed in hepatic artery via the left radial artery on liver malignancy].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheterization; Cisplatin; Colonic Neoplasms; Embolization, Therapeutic; Etoposide; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms | 1990 |
Combination therapy with platinum and etoposide of brain metastases from breast carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Platinum; Regression Analysis; Remission Induction | 1990 |
[Endodermal sinus tumor. Histological changes induced by chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Infant, Newborn; Liver Neoplasms; Male; Mesonephroma; Neoplasm Recurrence, Local; Sacrococcygeal Region; Teratoma; Time Factors | 1990 |
Combination chemotherapy with oral etoposide plus intravenous cyclophosphamide in liver metastases of breast cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Synergism; Etoposide; Female; Humans; Injections, Intravenous; Liver Neoplasms; Middle Aged; Remission Induction | 1990 |
A phase II study of etoposide in patients with hepatocellular carcinoma by the Tokyo Liver Cancer Chemotherapy Study Group.
Topics: Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Drug Evaluation; Etoposide; Female; Humans; Leukocyte Count; Liver Neoplasms; Male; Middle Aged; Platelet Count; Remission Induction | 1989 |
[A case of hepatocellular carcinoma effectively treated by intraarterial infusion of CDDP and other agents].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Embolization, Therapeutic; Etoposide; Fluorouracil; Humans; Iodized Oil; Liver Neoplasms; Male | 1989 |
[A case of intra-arterial infusion chemotherapy in small cell lung cancer with liver metastases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Etoposide; Hepatic Artery; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Remission Induction; Suspensions | 1989 |
Hepatic metastases in gestational trophoblastic disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Follow-Up Studies; Humans; Leukopenia; Liver Neoplasms; Methotrexate; Middle Aged; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms | 1986 |
A pleomorphic hepatocellular carcinoma with biochemical features of fibrolamellar hepatocellular carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Folic Acid; Humans; Liver Neoplasms; Neurotensin; Quinazolines; Vitamin B 12 | 1986 |
Long-term survival and complete response to adriamycin and etoposide in a case of hepatocellular carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; Etoposide; Female; Humans; Liver Neoplasms; Middle Aged | 1986 |
Phase 2 study of high dose etoposide (VP16-213) in hepatocellular carcinoma.
Topics: Blood; Carcinoma, Hepatocellular; Drug Evaluation; Etoposide; Humans; Liver Neoplasms | 1987 |
[The effect of etoposide (Et) on primary hepatocellular carcinoma].
Topics: Aged; Carcinoma, Hepatocellular; Etoposide; Female; Humans; Liver Neoplasms; Male; Middle Aged | 1987 |
Phase-II-study with EAP (etoposide, adriamycin, cis-platinum) in patients with primary inoperable gastric cancer and advanced disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Stomach Neoplasms | 1988 |